Document:

EX-10.3

 

EXHIBIT 10.3

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

TRUST DEED

Made and signed in Tel Aviv on December 21, 2005

	 	 	 	 	 
	Between:

	 	Cellcom Israel Ltd.	 	 
	 

	 	P.C. 511930125	 	 
	 

	 	10 Hagavish St., Netanya 42140	 	 
	 

	 	(the “Company”)
	 	of the one part
	 
	 	 	 	 
	A n d:

	 	Hermetic Trust (1975) Ltd.	 	 
	 

	 	Company no. 51-07051-9	 	 
	 

	 	113 Hayarakon St., Tel Aviv	 	 
	 

	 	(the “Trustee”)
	 	 of the other part

	 	 	 
	Whereas

	 	the Company decided to hold a private issue of a series of registered debentures unlimited in amount (series B), of
NIS 1 principal amount each; and
	 
	 	 
	Whereas

	 	the Trustee is a company limited by shares, incorporated in Israel, whose principal purpose is to engage in trusts; and
	 
	 	 
	Whereas

	 	the Trustee declared that there is no legal impediment to its entering into an engagement with the Company under this
Trust Deed, and that it meets the requirements and qualifying conditions set in the Securities Law, as hereinafter
defined, for acting as a trustee under this Trust Deed; and
	 
	 	 
	Whereas

	 	the Company requested the Trustee to act as trustee on behalf of the holders of Debentures (Series B), and the Trustee
agreed thereto, all subject to and in accordance with the terms of this Trust Deed.

     Therefore, it is hereby agreed, declared and stipulated between the parties as follows:

1. Preamble, Interpretation and Definitions

	 	1.1	 	The preamble to this Trust Deed and the appendices attached hereto form an
integral part hereof.
	 
	 	1.2	 	The division of this Trust Deed into clauses and assigning of clause headings is
done solely for convenience and as a means of reference, and may not be used for
purposes of interpretation.
	 
	 	1.3	 	Words stated in this Deed in the plural form import the singular form as well,
and vice versa; words stated in the masculine gender import the feminine gender as well,
and vice versa; and a person imports a corporation as well, wherever this

 

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	Deed does not provide explicitly and/or implicitly otherwise and/or the context or
content does not dictate otherwise.
	 
	 	1.4	 	Terms defined in the debenture certificate and not defined in this Trust Deed
shall have the meaning assigned to them in the debenture certificate.
	 
	 	1.5	 	In this Trust Deed the following terms shall have the meaning appearing alongside
them, unless implied differently by the context or content:
	 
	 	1.6	 	the “Trust Deed” or “this Deed” – this Trust Deed, including the appendices
attached hereto and forming an integral part thereof;
	 
	 	1.7	 	the “Debentures (Series B)” or the “debentures” – a series of registered
debentures (series B) unlimited in amount, of NIS 1 principal amount each, which are to
be issued by the Company under this Trust Deed;
	 
	 	1.8	 	“sum of net financial Indebtedness” known on any date – (a) the sum of the
Company’s indebtedness in respect of credit taken from financial institutions,
institutional investors and other holders of debentures of the Company, less (b)
short-term investments of the Company, including its cash balances and its deposits with
financial institutions, all as stated in the Company’s last financial statements,
audited or reviewed by the Company’s auditors and certified by the Company’s board of
directors prior to that date;
	 
	 	1.9	 	“financial debt” – the Company’s debt in respect of credit from a financial
institution or institutional investor or in respect of a debenture of the Company;
	 
	 	1.10	 	the “Trustee” – the Trustee mentioned at the head of this Deed and/or anyone
acting from time to time as trustee of the holders of the debentures under this Deed;
	 
	 	1.11	 	“register” – the register of holders of Debentures (Series B);
	 
	 	1.12	 	“debenture holder” or “holder” – the person whose name is written at the time in
question in the register as the holder of the debenture, and in the case of several
joint holders, the joint holder whose name is written first in the register;
	 
	 	1.13	 	“debenture certificate” – certificate of a Debenture (Series B), including the
appended “Terms set forth in the back of the page set forth in the back of the page” the
wording of which appears in Addendum A to this Deed;
	 
	 	1.14	 	the “Securities Law” – the Securities Law, 5728-1968, and its regulations as in
force from time to time;
	 
	 	1.15	 	“principal of the debentures” – the principal amount of the unpaid Debentures in
circulation;

- 2 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	1.16	 	“Consumer Price Index” or “index” – the price index known as “the Consumer Price
Index” including fruits and vegetables, published by the Central Bureau of Statistic and
Economic Research, including the same index even if published by another official
organization or institution replacing it, and whether built on the same data as the
existing index or not. If the index is replaced by another index published by an
organization or institution as aforesaid and such organization or institution has not
set the ratio between such index and the replaced index, said ratio shall be set by the
Central Bureau of Statistics. If such ratio is not set as aforesaid, then the Trustee in
consultation with economic experts to be chosen by it will set the ratio between the
other index and the replaced index;
	 
	 	1.17	 	“business day” – any day on which most of the big banks in Israel as well as the
Stock Exchange clearinghouse are open to the public for the execution of transactions;
	 
	 	1.18	 	“special resolution” – as defined in Addendum B to this Deed;
	 
	 	1.19	 	“calendar month” – according to the Gregorian calendar;
	 
	 	1.20	 	the “Stock Exchange” – the Tel Aviv Stock Exchange Ltd.
	 
	 	1.21	 	“EBITDA” in any period – the Company’s earnings before depreciation expenses,
financing, taxes and other deductions, all as stated in the Company’s financial
statements for that period, audited or reviewed by the Company’s auditors and certified
by the Company’s board of directors.

	2.	 	Issuance of the Debentures

	 	2.1	 	The Company will issue a series of registered debentures (series B) unlimited in
amount, of NIS 1 principal amount each, payable in 5 equal annual installments, on
January 5 of each calendar year, from January 5, 2013 to January 5, 2017 (inclusive),
bearing interest at a rate of 5.30% per annum and linked, principal and interest, to the
Consumer Price Index published for the month of November 2005.
	 
	 	2.2	 	The terms of the debentures will be as set out in this Deed and in the debenture
certificate (including the Terms set forth in the back of the page attached to the
certificate). The wording of the debenture certificate will be as set out in Addendum A
to this Deed.
	 
	 	2.3	 	The debenture certificates will be ready at the Company’s offices for delivery to
those entitled to them within three months from the date of the allotment of the
debentures, and they will be handed over against the return of the relevant allotment
letter to the Company.

- 3 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	2.4	 	Subject to the provisions of clause 2.5 below, the Debentures (Series B) will not
be listed on any stock exchange. Subject to the provisions of the law and to the Stock
Exchange rules, the Company will register the debentures in the name of the Registration
Company of Israel Discount Bank Ltd, and within 30 days from the date of their issuance
they will be registered at the Stock Exchange clearinghouse, which will provide clearing
services for the debentures, and they will also be listed in the computerized trading
system for institutional investors operated by the Stock Exchange (“listing in the
institutional continuous trading system”). Failure to list the debentures in the
institutional continuous trading system as aforesaid owing to an act or omission of the
Company shall be deemed a fundamental breach by the Company. It is hereby clarified that
subject to the provisions of the law and the Stock Exchange rules, other than an
institutional investor as defined in the First Schedule to the Securities Law,
5728-1968, no one may trade in the debentures in the framework of the computerized
trading system for institutional investors as stated.
	 
	 	2.5	 	The Company undertakes, subject to the provisions of any law and the Stock
Exchange rules, to list the debentures on the Stock Exchange on the basis of a
prospectus not later than June 30, 2006 (the “determining date for listing”). If the
debentures are not listed on the Stock Exchange by the determining date for listing,
then –

	 	2.5.1	 	The Company will notify the holders not later than July 5,
2006 that the Debentures (Series B) were not listed as stated. The debentures
will continue to be traded in the computerized trading system for institutional
investors, and the debenture holders will have the right (the “option”), as a
sole relief, to sell to the Company the Debentures (Series B) held by them, as
set out in this clause 2.5.
	 
	 	2.5.2	 	Any holder wanting to exercise the option (the “exerciser”)
will notify the Company in writing (“exercise notice”), not later than July 31,
2006, of his wish to exercise the option, specifying the total principal amount
of the Debentures (Series B) which he wishes to sell to the Company within the
exercise (the “value sold”), and if he is a holder whose name is not listed in
the register, he will attach to his notice a confirmation by the Stock Exchange
member attesting to his ownership of the value sold. The exerciser will attach
to the exercise notice a certificate of exemption from deduction of tax at
source, if such exists.
	 
	 	2.5.3	 	Not later than one business day before September 28, 2006
(“the first exercise date”), each exerciser will sell to the Company, in an
off-floor transaction, one-half of the value sold indicated in his exercise
notice, and where said one-half is not a sum of principal amount in whole new
shekels, the aforesaid total sum of principal amount will be rounded up to the
nearest new shekel (“the half”). In return, the Company will pay the exerciser,
on the first exercise date, within the off-floor transaction, the

- 4 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	outstanding balance of the unpaid principal of the half, plus linkage
differences, as well as the unpaid interest (together with linkage
differences), to which the exerciser is entitled for the half up to the
first exercise date according to the terms of the Debentures (Series B), and
which was not paid by then.
	 
	 	2.5.4	 	Not later than one business day before March 29, 2007 (the
“second exercise date”), each exerciser will sell to the Company, in an
off-floor transaction, the value sold indicated in his exercise notice less the
half (the “balance of the value sold”). In return, the Company will pay to the
exerciser, on the second exercise date, within the off-floor transaction, the
outstanding balance of the unpaid principal of the balance of the value sold,
plus linkage differences, as well as the unpaid interest (together with linkage
differences), to which the exerciser is entitled for the balance of the value
sold up to the second exercise date according to the terms of the Debentures
(Series B) and which was not paid by then.
	 
	 	2.5.5	 	Tax at source will be deducted from the amounts paid by the
Company under this clause, where this is required by law.
	 
	 	2.5.6	 	The exercise notice submitted to the Company may not be
canceled or modified. It is hereby clarified that the interest which the
Company shall pay under the terms of the Debentures (Series B) during the
period between July 31, 2006 and the first exercise date and the second
exercise date, as the case may be, will be paid to whoever are the holders of
Debentures (Series B) on the determining date for the payment of said interest.
	 
	 	2.5.7	 	The Company will notify the holders concerning the manner in
which the half and the balance of the value sold should be transferred to it,
not later than September 15, 2006.
	 
	 	2.5.8	 	If the sum of the value sold by all the exercisers according
to the exercise notices received by the Company will not be less than 90% of
the total principal amount of the Debentures (Series B) in circulation on July
31, 2006, then subject to the provisions of the law and the Stock Exchange
rules, the Company will be entitled to serve notice of the early redemption of
the Debentures (Series B) to take place on April 1, 2007
(the “early redemption
date”). Where the Company so chose –

	 	2.5.8.1	 	The debenture holders will be served a notice in this regard not
later than March 1, 2007, but not earlier than October 1, 2006. On the
date of service of the notice the Company will submit a report to the
Stock Exchange in which it indicates the exact rate of interest to be
paid to the holders on the early redemption date, calculated on the
basis of 365 days in a year.

- 5 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	2.5.8.2	 	On the early redemption date the Company will pay the holders the
balance of the unpaid principal and interest (together with linkage
differences) to which the holders are entitled up to the early
redemption date according to the terms of the Debentures (Series B).

	 	2.6	 	The Debentures (Series B) will stand pari passu among themselves, without any
priority or preference the one over the other.
	 
	 	2.7	 	The Company undertakes not to create liens on its assets, of any nature or kind,
for as long as the Debentures (Series B) have not been fully paid, excluding a fixed
lien on assets to secure credit enabling the purchase of those assets.
	 
	 	2.8	 	The Company undertakes to pay at the times appointed for this purpose in the
debentures the amounts of the principal, the interest and the linkage differences
payable under the debentures, and to comply with all the other conditions and
obligations imposed on it by the terms of the debentures and this Deed.

	3.	 	The Right to Issue Additional Debentures and Other Securities
	 
	 	 	The Company reserves the right to issue at any time additional debentures series or other
securities, with preferred, equal or inferior rights to the Debentures (Series B), whether
they confer or do not confer a right of conversion into shares of the Company and upon such
redemption, interest, linkage terms and other terms as the Company deems fit and subject to
the provision of clause 2.7 above, all as the Company deems fit, at its discretion, without
need of the consent of the Trustee or of the holders of Debentures (Series B) then in
circulation.
	 
	4.	 	The Right to Issue Additional Debentures (Series B)
	 
	 	 	The Company will be entitled, from time to time, at its sole discretion, to issue additional
Debentures (Series B), without need of the consent of the Trustee or of the holders of
Debentures (Series B) then in circulation (“the additional Debentures (Series B)”). Without
derogating from the generality of the above, the Company will be entitled to issue the
additional Debentures (Series B) at the same price or at a higher or lower price than the
price at which earlier debentures from series B were issued.
	 
	 	 	All the terms and provisions applying to the Debentures (Series B) will apply also to the
additional Debentures (Series B); to remove doubt, it is clarified that: (a) the principal of
the additional Debentures (Series B) will be paid, on every date of payment on account of the
principal, proportionally to the remaining number of principal payments; and (b) the holders
of the additional Debentures (Series B) will not be entitled to interest for interest periods
that ended prior to their allotment date.
	 
	 	 	The Company will notify the Trustee, and the Trustee will notify the debenture holders,
concerning the issuance of additional Debentures (Series B).

- 6 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	5.	 	Purchase of Debentures by the Company and Related Bodies
	 
	 	 	The Company reserves the right to purchase at any time debentures from this series, at any
price deemed appropriate by it, without derogating from the duty of payment of the balance of
the unpaid debentures in circulation. The purchase of the debentures by the Company will be
deemed as the redemption of those debentures, which will lapse; and if they were listed, then
they will also be canceled and delisted from trade trading system for institutional investors
or on the Stock Exchange, as the case may be, and the Company will not be allowed to reissue
them. It is hereby clarified that if such debentures are purchased by a subsidiary or by an
included company or by a related company of the Company (as this term is defined in the
Securities Law) controlling shareholder in the Company, this shall not be deemed as the
redemption of the debentures that were purchased by the subsidiary, the included company or
the controlling shareholders in the company as aforesaid; however, for as long as the
debentures are held by the subsidiary, the included company, the related company or the
controlling shareholders as aforesaid, they will not confer on their holders the right to
vote in general meetings of the debenture holders or taken into account for the purpose of
determining the presence of a quorum, except if any one of the above is an investor from
among those enumerated in the First Schedule to the Securities Law (in the matter of section
15A(b)(1) of the law), who is not investing on its own behalf (“related institutional
investor”), in which case its vote will be taken into account. It is hereby clarified that a
subsidiary, an included company, a related company or the controlling shareholder as
aforesaid not being related institutional investors will be entitled to participate in such
meetings, without a voting right.
	 
	 	 	The Company will notify the Trustee in any case of the purchase of debentures from this
series by it or by a subsidiary or by an included company or by the controlling shareholder
in the Company (upon learning thereof).
	 
	6.	 	No Collateral
	 
	 	 	The debentures are not secured by any collateral. The Company undertakes not to create liens
as provided in clause 2.7 above.
	 
	7.	 	Immediate payment on the Debentures
	 
	 	 	Subject to the provisions of clause 8 below, the Trustee will be entitled to make call for
the immediate payment on all or any of the unpaid balance of the debentures, and shall be
obligated to do so if required by a special resolution (as defined in Addendum B to this
Deed) passed by the general meeting of the debenture holders, or in a written demand signed
by the holders of more than 50% of the unpaid balance of the principal of the debentures in
circulation, all the aforesaid upon the occurrence of one or more of the circumstances
enumerated below:

	 	7.1	 	The Company will not pay any amount (whether principal, interest or linkage
differences) due under the terms of the debentures, within seven days from the due date
of that amount according to the terms of the debentures.

- 7 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	7.2	 	A permanent liquidator is appointed to the Company by a court, or the court
issues a final liquidation order in respect of the Company, or a valid resolution is
passed for the voluntary liquidation of the Company.
	 
	 	7.3	 	An application is filed for the Company to make an arrangement with its creditors
under section 350 of the Companies Law, 5759-1999, or a stay of proceedings order is
issued against the Company under the aforesaid section, and where the application is not
filed by the Company – the application or the order is not withdrawn or canceled within
45 days from when it was filed or issued, as the case may be.
	 
	 	7.4	 	The Company is dissolved or expunged for any reason whatsoever, including
expunction or dissolution for the purpose of a merger or in the framework of a share
swap, unless the Trustee is satisfied that the rights of the holders of Debentures
(Series B) will not be prejudiced by such merger or share swap transaction.
	 
	 	7.5	 	If any of the cases enumerated below take place, according to the determination
by the Trustee or in a special resolution passed by the general meeting of the debenture
holders that this may to prejudice or endanger the rights of the debenture holders:

	 	7.5.1	 	A temporary liquidator or temporary receiver is appointed to
the Company by a court, or if the court issues a temporary liquidation order
against the Company, and such appointment or order is not revoked within 30
days from when it was issued.
	 
	 	7.5.2	 	An attachment is imposed on material assets of the Company,
and such attachment is not lifted within 45 days from when it was imposed.
	 
	 	7.5.3	 	An execution act is executed against material assets of the
Company, and such act is not annulled within 45 days from when it was executed.
	 
	 	7.5.4	 	A permanent receiver is appointed to the Company and/or over
all or a material part of its assets, and such appointment is not revoked
within 45 days.
	 
	 	7.5.5	 	The Company discontinues payments and/or gives notice of its
intention to discontinue payments and/or there is, in the Trustee’s opinion, a
real danger that it will discontinue payments and/or cease carrying on its
business and/or it is probable that it will cease carrying on its business.
	 
	 	7.5.6	 	The Company breaches or defaults on any material condition or
obligation imposed on it by the terms of the debentures and this Deed, and
fails to remedy such breach within 14 business days from when it received a
written warning from the Trustee to remedy the breach.

- 8 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	7.5.7	 	The holders of liens on the Company’s assets exercise their
liens on material assets of the Company.
	 
	 	7.5.8	 	A call for an immediate payment is made on another debenture
series that was issued by the Company, not in accordance with a resolution of
the Company.
	 
	 	7.5.9	 	So long as the debentures have not been listed on the Stock
Exchange – if 10 business days have elapsed from when a call for an immediate
payment was made upon a financial debt by a creditor, consequent on a breach of
the Company’s obligations toward such creditor; however, if in the course of
those 10 business days any of the circumstances listed below occurs, no call
for an immediate payment will be made on the Debentures (Series B): (1) an
order is issued for the stay or cancellation of the call for an immediate
payment on the financial debt; (2) the Company and the creditor arrive at an
arrangement in which the call for an immediate payment is canceled, in such
manner that it does not advance the original payment times that were fixed
between such creditor and the Company.
	 
	 	 	 	In this regard, “financial debt” – excluding existing indebtedness of the
Company to banks in their amount on December 31, 2005.
	 
	 	7.5.10	 	Up to the listing of the debentures on the Stock Exchange – the transfer of
control in the Company. In this regard, “control” – as defined in the
Securities Law, except if the identity of the new holder of the controlling
shareholder was approved by a meeting of the holders of Debentures (Series B).
	 
	 	7.5.11	 	Up to the listing of the debentures on the Stock Exchange – any other event
which, in the Trustee’s reasonable opinion, constitutes a material injury
and/or gives rise to a real concern of material injury to the rights of the
holders of Debentures (Series B), including due to events as aforementioned in
the beginning of this clause 7.5.11, coming to the Trustee’s attention pursuant
to notices of the Company served as provided in clause 15.13 below.

8. Prior Notice Before a Call for Immediate Payment

	 	8.1	 	Notwithstanding the aforesaid in clause 7 above, the Trustee will not make a call
for an immediate payment on the debentures unless the Trustee served the Company prior
written notice of its intention to do so, and the Company failed to comply with the
contents of such notice within 15 days from the receipt thereof (“the curing period”).
	 
	 	8.2	 	In the prior notice as aforesaid the Company will be required to pay the amount
in arrears, and/or to comply with the other provisions of this Trust Deed or terms of
the debentures the breach of which or noncompliance with which constitute cause

- 9 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	for making a call for an immediate payment, and/or to restore the status quo
according to the event set forth in clause 7 above constituting cause for a call for
an immediate payment, in respect of which the aforesaid notice was served.
	 
	 	8.3	 	Notwithstanding the provisions of clause 8.1 above, if the Trustee is of the
opinion that a delay in making a call for an immediate payment on the Company’s debt, as
stated in clause 8.1 above, will materially endanger the rights of the debenture
holders, it will be entitled to shorten the curing period up to 3 business days, in
order to prevent such danger to the rights of the debenture holders, provided it affirms
this to the Company in a notice served to it simultaneously with the call for an
immediate payment on the debentures.

9. Claims and Proceedings by the Trustee

	 	9.1	 	Whenever a call for an immediate payment is made on the debentures, the Trustee
will be entitled, at its discretion and without further notice, to institute such
proceedings, including legal proceedings, as it deems fit for protecting the rights of
the debenture holders.
	 
	 	9.2	 	The Trustee shall be obligated to act as provided in clause 9.1 above, if so
required by a special resolution passed by the general meeting of the debenture holders,
or in a written demand signed by the holders of more than 75% of the unpaid balance of
the principal of the debentures in circulation, and in accordance with such resolution
or demand, unless the Trustee deems it unjustified and/or unreasonable to do so in the
circumstances of the case and applies to the appropriate court for instructions in the
matter.
	 
	 	9.3	 	The Trustee may, before instituting any proceedings to convene a meeting of the
debenture holders to issue a special resolution as to which proceedings should be
instituted, and the Trustee will be entitled to reconvene meetings of the debenture
holders for the purpose of receiving instructions in respect of the conduct of such
proceedings.
	 
	 	9.4	 	The stated above shall not prejudice and/or derogate from the Trustee’s right to
initiate legal and/or other proceedings including the receipt of instructions from the
court, even if no call for payment was made on the debentures, all for the protection of
the debenture holders and subject to the provisions of any law.
	 
	 	9.5	 	Subject to the provisions of this Deed, the Trustee is entitled, but not
obligated, to convene a general meeting of the debenture holders at any time, in order
to consider any matter relating to this Deed and/or to obtain its instructions in that
regard.
	 
	 	9.6	 	The Trustee is entitled, but not obligated, at its sole discretion, to delay the
performance of any action under this Deed, for the purpose of applying to the general
meeting of the debenture holders and/or to the court, until it receives

- 10 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	instructions from the general meeting of the debenture holders and/or from the court
on how to proceed.
	 
	 	9.7	 	The application to the general meeting of the debenture holders and/or to the
court will be made in such cases without delay and at the earliest possible and
reasonable date.

10. Trusteeship of the Receipts

	 	10.1	 	All the receipts received by the Trustee, including as a result of proceedings,
if any, instituted by it against the Company, will be held by it in trust and used by it
for the purposes and according to the order or priorities detailed below:
	 
	 	 	 	First, for defraying the reasonable costs, the payments, the imposts and the
obligations that were expended by the Trustee, imposed on it, or that were incurred
incidentally to or in consequence of the trust execution acts or otherwise in
connection with the terms of this Deed, including the Trustee’s fee (provided it was
not paid by the Company, and without derogating from its obligation to pay the
Trustee’s fee). Subject to the provisions of the law, the balance will be used by
the Trustee, unless the general meeting of the debenture holders directs otherwise
in a special resolution, for the following: first, to pay the debenture holders all
the interest due to them under the terms of the debentures, subject to the linkage
conditions in the debentures, pari passu and pro rata to the amount of the arrears
interest due to each of them, without preference or priority to any of them and
without any preference due to precedence in the time of issuance of the debentures
by the Company or otherwise; second, to pay the debenture holders the principal
amounts due to them under the debentures held by them, whether the time of payment
of the principal has arrived or not, subject to the linkage conditions in the
debentures, pari passu and pro rata to the amounts due to them, without any
preference due to precedence in the time of issuance of the debentures by the
Company or otherwise, and the surplus, if any, will be paid by the Trustee to the
Company or its substitutes, as the case may be. Withholding tax will be deducted
from the payments to the debenture holders, insofar as there is a requirement in law
to do so.
	 
	 	 	 	The payment of the amounts by the Trustee to the debenture holders as stated above,
from the receipts received by it, is subject to prior or equal rights of other
creditors of the Company with respect to said receipts, should there be any such and
in accordance with any law.

11. Authority to Delay the Distribution of Moneys

	 	11.1	 	Notwithstanding the provisions of clause 10 above, if the monetary amount
received as a result of the institution of proceedings as stated above and becoming
distributable at any time as stated in said clause, is less than ten percent (10%) of
the unpaid balance of the principal of the debentures in circulation (subject to the

- 11 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	linkage conditions), the Trustee will not be obligated to distribute it and will be
entitled to invest such amount, wholly or partly, in the permissible investments
under this Deed and to replace such investments from time to time with other
permissible investments, all as he deems appropriate.
	 
	 	11.2	 	When the aforesaid investments with their earnings, together with other moneys,
if any, received by the Trustee for payment to the debenture holders, reach an amount
sufficient for paying at least ten percent (10%) of the unpaid balance of the principal
of the debentures in circulation (subject to the linkage conditions), the Trustee will
pay them to the debenture holders in the manner provided in clause 10 above. That stated
will not apply if a special resolution is passed by the general meeting of holders of
Debentures (Series B) according to which the Trustee is required to distribute such
amount.
	 
	 	11.3	 	If within a reasonable amount of time the Trustee is not in possession of an
amount sufficient for paying at least ten percent of the unpaid balance of the principal
of the debentures as stated, it will be entitled to distribute to the debenture holders
the moneys in his possession.

	12.	 	Distribution Notice
	 
	 	 	The Trustee will notify the debenture holders of the day and place of execution of any
payment from among those referred to in clauses 10 and 11 above, by a prior notice of 14 days
to be served in the manner specified in clause 24 below.
	 
	 	 	After the day specified in the notice, the debenture holders will be entitled to interest at
the rate specified in the debentures, only on the balance of the principal (should there be
any such) after deduction of the amount that was paid or proposed for payment to them as
aforesaid.
	 
	13.	 	Receipts from the Debenture Holders

	 	13.1	 	A receipt issued by a debenture holder for the amounts of the principal, the
interest and the linkage differences paid to him by the Trustee in respect of the
debenture will release the Trustee absolutely with respect to the actual execution of
payment of the amounts specified therein.
	 
	 	13.2	 	A receipt issued by the Trustee for the amounts of the principal, the interest
and the linkage differences deposited with it in favor of the debenture holders in
accordance with the terms of this Deed or the debentures, will be deemed vis-à-vis the
Company as a receipt from the debenture holder regarding the receipt of the amounts
specified therein.

14. Presentation of a Debenture to the Trustee and Recording of a Partial Payment

	 	14.1	 	A debenture holder will be obligated to present to the Trustee, at the time of a
payment on account of principal, interest or linkage differences under clauses 10, 11
and 12 above, the debenture in respect of which the payment is being made.

- 12 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	14.2	 	The Trustee will record on the debenture certificate a note concerning the
amounts that were paid as aforesaid, and the payment date.
	 
	 	14.3	 	The Trustee will be entitled, in any special case, at its discretion, to waive
the presentation of the debenture, after the debenture holder provided it with an
indemnity letter and/or a security deemed adequate by the Trustee for damages that may
be caused by the non-recording of a note as aforesaid, all as the Trustee deems fit, or
it may maintain records in another manner, at its discretion.

	15.	 	Company’s Undertakings Toward the Trustee
	 
	 	 	The Company hereby undertakes toward the Trustee, up to the date of full payment of the
debentures, as follows:

	 	15.1	 	To persist and conduct its business in an orderly and proper manner, including
making the mandatory payments applying by law to its assets. It is hereby clarified that
the Company’s failure to make such a mandatory payment due to a disagreement in good
faith shall not be deemed a breach of this undertaking.
	 
	 	15.2	 	To notify the Trustee in writing, directly and not later than 2 business days
after learning of the imposition of any attachment on all or a material part of its
assets, and of the appointment of a receiver and/or special administrator and/or
temporary or permanent liquidator over all or a material part of its assets, and of an
action by a holder of a lien on any asset of the Company for the exercise of the lien
registered in its favor, and to take, at its expense, all the necessary steps for
removing such attachment or for canceling such receivership, liquidation or
administration or for annulling the lien exercise actions, as the case may be.
	 
	 	15.3	 	To notify the Trustee in writing, directly and not later than 2 business days
after learning of the occurrence of any of the circumstances enumerated in clause 7
above.
	 
	 	15.4	 	To comply with any other reasonable instruction of the Trustee that is intended
to protect the rights of the debenture holders, all in accordance with the provisions of
this Deed.
	 
	 	15.5	 	To manage its books in accordance with the provisions of any law and generally
accepted accounting principles, and to allow the Trustee or its authorized
representative, upon its demand, to inspect the Company’s books and the documents
serving as references therefore, subject to the Trustee’s undertaking to keep the
information in confidence, except for the conveyance of relevant information only, at
the Trustee’s reasonable discretion, to a meeting of the debenture holders that was
convened for the purpose of receiving a report and/or passing an ordinary and/or special
resolution. The holders undertake toward the Trustee and the Company to keep in
confidence any information brought before them, for as long as it has not been made
public by the Company. In this regard, the Trustee’s authorized representative denotes
anyone appointed by the Trustee

- 13 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	for the purpose of such inspection in a written notice to be served by the Trustee
to the Company prior the aforesaid inspection, said notice to include also the
Trustee’s confirmation that such representative is obligated toward the Trustee and
toward the Company to keep in confidence any information coming to his knowledge in
the course of his activity on the Trustee’s behalf. The Trustee will keep in
confidence any information contained in a book and/or in a document inspected by the
Trustee’s representative as stated.
	 
	 	15.6	 	To furnish to the Trustee a copy of every report which it is obligated to submit
to the Securities Authority, simultaneously with the submission thereof to the
authority, as well as a copy of every document transmitted by the Company to the
debenture holders. In addition the Company will transmit to the Trustee additional
information relating to the Company, upon the Trustee’s reasonable demand, and any
information transmitted to the Trustee will be kept in confidence by it.
	 
	 	15.7	 	To issue to the Trustee, once a year as well as upon demand, a confirmation that
all the payments coming due were made to the debenture holders.
	 
	 	15.8	 	To cause the debentures to be rated by a rating agency throughout the term of the
debentures. In this regard, “rating agency” – as this term is defined in the Second
Schedule to the Securities Regulations (Details of the Prospectus, Its Structure and
Form), 5729-1969.
	 
	 	15.9	 	To enable the Trustee to participate in meetings of the Company’s shareholders,
without a voting right.
	 
	 	15.10	 	For as long as the debentures have not been listed on the Stock Exchange – to
notify the Trustee in writing in the event that a call for an immediate payment is made
on a financial debt of the Company by a creditor pursuant to a breach of the Company’s
obligations toward that creditor, directly and not later than 2 business days after the
Company learned thereof. In this regard, “financial debt” – excluding existing
indebtedness of the Company to banks in their amount on December 13, 2005.
	 
	 	15.11	 	For as long as the debentures have not been listed on the Stock Exchange – the
Company will not distribute a dividend if the Company’s known net financial indebtedness
on the distribution date exceed three times the accumulated EBITDA in the four last
calendar months included in the Company’s financial statements certified by its board of
directors prior to the distribution date. The Company undertakes to present to the
Trustee a written confirmation from the Company’s accountant, not later than 3 business
days before the date of the announcement of a dividend distribution, concerning its
absolute compliance with the above condition.
	 
	 	15.12	 	Up to the listing of the debentures on the Stock Exchange – to notify the
Trustee in writing, directly and not later than 2 business days after learning of any
case in

- 14 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	which following the first issue of the debentures under this Deed, the Company is to
assume a new or additional financial debt in a manner that increases by more than
NIS 500 million its known net financial Indebtedness on the date of assumption of
such financial debt.
	 
	 	15.13	 	For as long as the debentures have not been listed on the Stock Exchange, the
Company undertakes to notify the Trustee in writing, directly and not later than two
business days after learning of any occurrence or matter being outside the ordinary
course of the Company’s business in view of their nature, scope or potential
consequence, and which have or could have a material effect on the Company.

	16.	 	Additional Undertakings
	 
	 	 	After a call for an immediate payment is made on the debentures, the Company will perform,
from time to time and whenever so required by the Trustee, all reasonable actions to enable
the exercise of all the powers vested in the Trustee and specifically, the Company will
perform the following actions, insofar as they are reasonable:

	 	16.1	 	Make any declaration and/or sign all documents and/or perform and/or cause the
performance of all actions as necessary and/or required for validating the exercise of
the authorities, the powers and the authorizations of the Trustee and/or its
representatives.
	 
	 	16.2	 	Issue all notices, orders and instructions as the Trustee deems practicable and
which it requires.
	 
	 	16.3	 	For the purposes of this clause – a written notice signed by the Trustee,
confirming that an action required by it, within the framework of its powers, is a
reasonable action, shall be prima facie evidence thereof.

17. Attorneys

	 	17.1	 	The Company hereby irrevocably appoints the Trustee as its attorney for
implementing and performing in its name and stead all the actions which it is obligated
to perform by the explicit terms of this Deed, and in general to act in the Company’s
name in the exercise of all or a part of the powers vested in the Trustee, and to
appoint any other person as the Trustee deems fit for the performance of the Trustee’s
duties under this Deed of Trust, provided the Company has not performed the actions
which it is obligated to perform by the terms of this Deed within a reasonable time from
the Trustee’s demand.
	 
	 	17.2	 	The appointment under clause 17.1 above shall not obligate the Trustee to perform
any action, and the Company hereby discharges the Trustee in advance in the event that
it does not perform some action as aforesaid in clause 17.1 and/or in the event it is
not performed on time. Additionally, the Company hereby waives in advance any contention
against the Trustee and/or its agents for any damage

- 15 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	caused and/or may be caused to the Company, directly and/or indirectly, due to
actions in good faith that were performed by the Trustee as stated in this clause,
excluding negligence and/or mala fides on the part of the Trustee.

	18.	 	Other Agreements
	 
	 	 	Subject to the provisions of the Securities Law and to the restrictions imposed on the
Trustee in the Securities Law, the fulfillment of the Trustee’s function under this Deed or
its status per se as a trustee shall not prevent the Trustee and/or its parent company and/or
any related company from entering into various contracts with the Company or from executing
any transaction with any third party in the ordinary course of its business, including any
contract or transaction relating to the underwriting, distribution or sale of shares,
debentures or other securities of the Company, provided this does not affect the fulfillment
of the Trustee’s undertakings in this Deed or the Trustee’s competency.
	 
	19.	 	Reports by the Trustee
	 
	 	 	The Trustee will prepare by the end of the second quarter in each calendar year an annual
report concerning the affairs of the trust (“the annual report”). The annual report will set
out the following matters:

	 	19.1	 	Current details of the course of the affairs of the trust during the past
calendar year.
	 
	 	19.2	 	Exceptional events connected with the trust that occurred during the past
calendar year.
	 
	 	19.3	 	The holders may inspect the annual report at the Trustee’s offices during regular
business hours, and they may receive a copy of the report upon demand.
	 
	 	19.4	 	The Trustee will notify the holders of the date of submission of the report by
it, as provided in clause 23 below.
	 
	 	19.5	 	If the Trustee learns of a material breach of the Trust Deed on the Company’s
part, it will notify the holders of the breach and of the steps it has taken for the
prevention thereof or for the fulfillment of the Company’s undertakings, as the case may
be.

	20.	 	Trustee’s Fee
	 
	 	 	The Trustee’s fee will be as specified in Addendum C to this Deed.
	 
	21.	 	Powers and Activities

	 	21.1	 	The Trustee is not obligated to inform any part of the signing of this Deed and
may not interfere in any manner in the conduct of the Company’s business or affairs.

- 16 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	21.2	 	The Trustee will exercise in trust the powers, authorizations and authorities
vested in it by this Deed, at its reasonable discretion, and it shall not be liable for
any damage caused due to an error in such discretion, unless it acted negligently or
mala fides.
	 
	 	21.3	 	The Trustee will keep in confidence any information conveyed to it by the Company
and will not make any use thereof save for the purpose of fulfilling its obligations
under the terms of this Deed, including for the purpose of conveying relevant
information only, at its reasonable discretion, to a meeting of the debenture holders
convened to receive a report and/or pass an ordinary and/or special resolution. The
holders undertake toward the Trustee and the Company to keep in confidence the
information brought before them, for as long as it has not been made public by the
Company.
	 
	 	21.4	 	The Trustee may in the course of executing the trust affairs under this Deed act
on the opinion and/or advice of any lawyer, accountant, appraiser, assessor, surveyor,
broker or other expert, whether such opinion and/or advice was prepared at the Trustee’s
request and/or by the Company, and the Trustee will not be liable for any loss or damage
caused as a result of any action and/or omission done by it on the basis of such advice
or opinion, unless the Trustee acted negligently or not in good faith. The Trustee will
allow the Company and the debenture holders to peruse such opinion upon demand.
	 
	 	21.5	 	Any such advice and/or opinion may be given, sent or received by letter, cable,
facsimile and/or any other electronic means for the transmission of information, and the
Trustee shall not be liable for actions done by it on the basis of any advice and/or
opinion and/or knowledge conveyed by one of the methods mentioned above, even if it
contained errors and/or was inauthentic, unless it was possible to discover such errors
in a reasonable examination.
	 
	 	21.6	 	The Trustee will be entitled to appoint an agent/s to act in its stead, be it a
lawyer or someone else, for the purpose of performing or participating in the
performance of special actions that are required in connection with the trust – and
without derogating from the above generalities, the institution of legal proceedings or
representation in merger or spin-off processes of the Company – and to pay any such
agent a fee. The Company shall be entitled to object to such appointment fot any
reasonable reason, including in case the agent is competing, directly and indirectly,
eith the company’s business.
	 
	 	21.7	 	Subject to the provisions in this Deed, the Trustee will act toward the debenture
holders in accordance with the provisions of the Securities Law, even before the listing
of the Debentures (Series B) on the Stock Exchange.

22. Indemnification of the Trustee

	 	22.1	 	The Trustee will be entitled to indemnity from the debenture holders and/or from
the Company, as the case may be, for reasonable costs which it incurred and/or

- 17 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	will incur, as the case may be, in connection with actions which it performed and/or
will be required to perform by virtue of its obligation under the terms of the Trust
Deed and/or by law and/or statute and/or by order of a competent authority and/or by
demand of the debenture holders, in the manner specified in the Trust Deed, or by
demand of the Company, but it: will not be entitled to demand indemnity in advance
in a matter that does not brook delay; and where the Trustee is satisfied with an
indemnity undertaking – such indemnity undertaking may include indemnity in respect
of liability in torts that is imposed on the Trustee in a final judgment or in a
compromise vis-à-vis a third party not being a debenture holder, provided that such
indemnity undertaking is subject to the following conditions: 1) the costs in
respect of the liability in torts are reasonable; 2) the Trustee acted in good faith
and with appropriate care, and such action was done during the fulfillment of its
function and without negligence.
	 
	 	22.2	 	Without derogating from the rights to compensation granted to the Trustee by
law, but subject to the provisions of clause 22.1 above, the Trustee and any receiver,
representative, manager, agent or other person appointed by the Trustee under this Deed,
will be entitled to be indemnified from the moneys received by the Trustee in
proceedings instituted by it or in another manner under this Deed, with respect to
obligations which they assumed, with respect to costs which they incurred incidentally
to the execution of the trust under this Deed, or in connection with such actions as in
their opinion were required for such execution, or in connection with the exercise of
the powers and authorities vested in them by virtue of this Deed, and in connection with
all kinds of legal proceedings, opinions and advice of lawyers and other experts,
negotiations, deliberations, expenses, claims and demands relating to any law or any
thing that was done or not done in any manner in such regard, and the Trustee will be
entitled to withhold the moneys in its possession and to pay out of them the amounts
required as indemnity, provided it did not act negligently.
	 
	 	 	 	Whenever the Trustee is obligated by the terms of the Trust Deed and/or by law
and/or statute and/or by order of a competent authority and/or by demand of the
debenture holders (Series B) and/or by demand of the Company to perform any action,
including but not only the initiation of proceedings or filing of claims at the
demand of the owners of Debentures (Series B), as stated in the Trust Deed, the
Trustee will be entitled to abstain from any such action until it receives an
indemnity letter, to its satisfaction, from the owners of Debentures (Series B) or
any of them, and where the action is performed pursuant to the Company’s demand –
from the Company, in respect of any liability for damages and/or costs that could be
caused to the Trustee, to the Company or to either of them due to the performance of
such action. All the foregoing, except in circumstances in which an urgent action
was required, and abstention from the performance thereof before the receipt of an
indemnity letter as stated would cause damage and/or loss to the holders of
Debentures (Series B).

- 18 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

23. Notices

	 	23.1	 	Any notice served by the Company and/or the Trustee to the debenture holders will
be sent by registered post to the address of the debenture holders last recorded in the
register, and any notice sent as stated will be deemed to have been served to the
debenture holders at the end of three days from the date of delivery thereof at the post
office.
	 
	 	 	 	The Trustee will send the Company copies of notices and invitations served by it to
the debenture holders.
	 
	 	 	 	The Company will send the Trustee copies of notices and invitations served by it to
the debenture holders.
	 
	 	 	 	However in the event that the debentures are listed on the Stock Exchange or in the
computerized system for trade in institutional securities operated by the Stock
Exchange, a notice by the Company and/or the Trustee to the debenture holders may,
instead of being sent by registered post, be served to the registration company and
by publication in at least two widely circulated daily newspapers published in
Israel in the Hebrew language, and in such case, the day of publication will be
deemed as the day of receipt of the notice by the debenture holders.
	 
	 	23.2	 	Any notice or demand by the Trustee to the Company or by the Company to the
Trustee may be served in a registered letter sent to the address detailed in this Deed,
or to another address of which one party will inform the other in writing, or by a fax
transmission or by messenger, and every such notice or demand will be deemed to have
been received by the addressee as follows: (a) if sent by registered post – at the end
of three business days from the day of its delivery at the post office; (b) if
transmitted by fax (together with verification of receipt by telephone) – at the end of
one business day from the day of its transmission; and (c) if sent by messenger – upon
delivery of the notice or offering thereof to the addressee, as the case may be.

24. Alterations to the Trust Deed; Waiver and Compromise; Modification of Rights

	 	24.1	 	Subject to the provisions of any law, the Company and the Trustee will be
entitled to alter the terms of the Trust Deed (including an alteration in the terms of
the debentures), upon the fulfillment of any of the following:

	 	24.1.1	 	The Trustee is satisfied that the alteration does not prejudice the rights of
the debenture holders. Notwithstanding the aforesaid, no alteration may be made
to the terms of the Trust Deed and/or the debentures in regards with the
amounts and times of payment, the causes for making a call for an immediate
payment for payment and/or the reports which the Company is required to submit
to the Trustee, except as provided in clause 24.1.2 below.

- 19 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	24.1.2	 	The debentures holders have agreed to the alteration in a special resolution
(as defined in Addendum B to this Deed) passed in a meeting of the debenture
holders.

	 	24.2	 	The Trustee will be entitled, where he is satisfied that this does not prejudice
the rights of the debenture holders, to waive any nonmaterial breach or nonmaterial
compliance by the Company with any condition of the Deed of Trust (or condition of the
debentures), excluding a breach and/or noncompliance with conditions as stated relating
to the payment of amounts to debenture holders and/or times of payment and /or reports
the Company has to deliver to the Trustee.
	 
	 	24.3	 	Furthermore, the Trustee will be entitled, subject to the provisions of the law,
with prior approval by a special resolution passed in the general meeting of the
debenture holders, whether before or after a call for an immediate payment has been made
on the debentures, to compromise with the Company in connection with any right or claim
of the debenture holders or any of them and to agree with the Company on any settlement
of rights of the debenture holders under the Trust Deed and according to the terms of
the debentures, and inter alia to waive any right or claim of the debenture holders
against the Company.
	 
	 	24.4	 	Notwithstanding the aforesaid, the Trustee will be entitled, at the Company’s
request, from time to time and at any time, until the listing of the debentures on the
Stock Exchange, to make alterations in the Trust Deed and/or in the debentures as
required by the Securities Authority and/or the Stock Exchange and/or any other
governmental authority, insofar as such alterations are necessary for listing on the
Stock Exchange, provided such alterations do not, in the Trustee’s opinion, prejudice
the rights of the debenture holders and/or change the causes for immediate payment and
the amounts and times of payment of the debentures. Up to the listing of the debentures
on the Stock Exchange, the Company will serve the debenture holders written notice of
any such alteration as soon as possible after it was made.
	 
	 	24.5	 	Starting from the date of listing of the debentures on the Stock Exchange, the
Company will issue an immediate report concerning any alteration as stated above in this
clause 24 (including all its sub-clauses) immediately after it was made. So long as the
debentures have not been listed on the Stock Exchange, the Company will serve the
holders notice of any alteration as stated above in this clause 24 (including all its
sub-clauses) immediately after it was made.
	 
	 	24.6	 	Whenever the Trustee exercises its right under this clause, it will be entitled
to require the debenture holders to deliver the debenture certificates to it or to the
Company, for the purpose of recording thereon a note concerning any compromise, waiver,
alteration or amendment as stated, and upon the Trustee’s demand the Company will record
a note as aforesaid. Whenever the Trustee exercises its right under this clause, it will
notify the debenture holders in writing in that regard within a reasonable time.

- 20 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

25. Register of the Debenture Holders

	 	25.1	 	The Company will maintain and manage in its registered office a register of the
debenture holders, in which will be recorded the names of the debenture holders, their
address and the number and principal amount of the debentures registered in their name.
All transfers of title to the debentures in accordance with the provisions of this Deed
and the debentures will be registered in the register. The Trustee and any debenture
holder will be entitled to inspect the register at any reasonable time. The Company may
close the register from time to time for a period or periods not exceeding 30 days in
the aggregate in a year.
	 
	 	25.2	 	The Company will not be obligated to record in the register of the debenture
holders any notice concerning an explicit, implicit or presumed trust, or any pledge or
lien of any kind, or any equitable right, claim or offset or other right in connection
with the debentures. The Company will recognize solely the title of the person in whose
name the debentures were registered, provided the legal heirs, administrators or
executors of the registered owner and any person becoming entitled to the debentures by
reason of the bankruptcy of the registered owner (and in the case of a corporation – by
reason of its liquidation), will be entitled to be registered as the owner thereof after
providing adequate proof to the Company’s satisfaction of their right to be so
registered.

	26.	 	Release
	 
	 	 	Upon proof to the Trustee’s satisfaction that all the debentures were fully paid and redeemed
(including principal, interest and linkage differences), and upon proof to the Trustee’s
satisfaction that all the obligations or costs incurred by the Trustee in connection with
this Deed were fully defrayed, the Trustee will be obligated, upon the Company’s first
demand, to act with any unredeemed moneys deposited in regard of the debenture in accordance
with the conditions specified in this Deed.
	 
	27.	 	Termination of the Trustee’s Office

	 	27.1	 	The Trustee and any trustee replacing it will be entitled to resign from their
office whenever they so desire, after serving the Company a written notice setting out
the reason for the resignation. If the debentures have not been listed on the Stock
Exchange, the Company will convene a meeting of the holders of Debentures (Series B) to
appoint a new trustee, and the Trustee’s resignation will take effect upon the
appointment of the new trustee. The new trustee will be a trust company of one of the
six big banks in Israel or another trustee whose appointment has been approved by a
meeting of the debenture holders.
	 
	 	 	 	If the debentures have been listed on the Stock Exchange, the Trustee’s resignation
will take effect only after it has been approved by the court and from the day
specified in the approval. Upon the resignation of the Trustee, the court will
appoint a new trustee in its place.

- 21 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	27.2	 	The Trustee will transfer to the new trustee all its records concerning holders
of Debentures (Series B), if there are any such, information concerning the payments
that were executed by the Trustee until then, if any such were executed, any report that
was submitted according to the terms of the Trust Deed and any information reasonably
required by the new trustee, and the Trustee will transfer as well to the new trustee
any amount held by it at the time in connection with the Debentures (Series B).
	 
	 	27.3	 	The holders of ten percent (10%) of the balance of the principal amount of the
Debentures (Series B) may convene a general meeting of the debenture holders, which may
resolve, upon a vote of the holders of at least fifty percent (50%) of the balance of
the principal amount of the Debentures (Series B), to dismiss the Trustee.
	 
	 	27.4	 	Without derogating from the aforesaid, the Trustee’s office will expire or
terminate, as the case may be, in the circumstances enumerated in section 35N of the
Securities Law.
	 
	 	27.5	 	Prior to the appointment of a new trustee not being a trust company of a bank,
the Company will provide to the holders details of such trustee’s equity and insurance
arrangements in connection with the fulfillment of its function as trustee.
	 
	 	27.6	 	Without derogating from the aforesaid, the Trustee’s office will terminate if it
becomes apparent that the Trustee is precluded from continuing in office due to a change
in the provisions of the law or the statute applying to its competence to serve as
trustee, including where such preclusion is created in connection with the listing of
the debentures on the Stock Exchange. For this purpose “preclusion” is deemed also a
demand by the Securities Authority to terminate the Trustee’s office. In such case the
Company will appoint a new trustee.
	 
	 	27.7	 	Any new trustee appointed will have the same powers, authorities and other
authorizations and will be able to act, in all respects, as if it had to begin with been
appointed as the Trustee.
	 
	 	27.8	 	The Company will notify the holders upon learning of any event and/or
circumstance by reason of which the Trustee is precluded from continuing in office.

	28.	 	Meetings of the Debenture Holders
	 
	 	 	Meetings of the debenture holders will be conducted as set forth in Addendum B to this Deed.
	 
	29.	 	Financial Statements
	 
	 	 	The Company will submit to the Trustee, for as long as all the debentures have not been fully
paid (including interest and linkage differences):

- 22 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	29.1	 	Audited financial statements of the Company for the fiscal year ended December 31
of the past year, immediately upon the presentation thereof to the Company’s
shareholders and not later than the date on which a public company is required to
publish these statements.
	 
	 	29.2	 	Any semi-annual and quarterly interim report, immediately upon the presentation
thereof to the Company’s shareholders and not later than the date on which a public
company is required to publish these reports, together with the review thereof of the
Company’s accountant.
	 
	 	29.3	 	Certification of the Company’s accountant and/or controller concerning the
payment of any interest and/or principal and the date of payment thereof to the
debentures holders, and the balance of the principal amount of the debentures in
circulation, pursuant to the Trustee’s written request to the Company for such a
certification.
	 
	 	29.4	 	Any immediate report submitted by the Company, immediately upon its publication.
	 
	 	29.5	 	In the event that the debentures are delisted from trade following the listing
thereof, and for as long as all the Debentures (Series B) have not been fully redeemed,
the Company will continue submitting to the Trustee the reports detailed in clauses 29.1
and 29.2 above, at the times when a public company is required to publish these reports.
	 
	 	29.6	 	Reports concerning any change in the rating of the debentures.
	 
	 	29.7	 	The Trustee will allow the holders to inspect the reports, subject to their
undertaking to maintain confidentiality as set out in clause 21.3 above.

	30.	 	Investments of Moneys 
	 
	 	 	All the moneys which the Trustee is entitled to invest under this Deed, will be invested by
the Trustee, in a bank/s, in its name or to its order, in investments which under the laws of
the State of Israel are permissible with trust moneys, as it deems appropriate, subject to
the terms of this Trust Deed and provided that any investment in securities is limited to
securities with a rating of not less than AA. If the Trustee does so, it will owe the persons
entitled to those amounts only the proceeds obtained from the realization of the investments,
less related costs, management costs of the trust accounts, commissions and other mandatory
payments applying to the trust account. From such moneys the Trustee will transfer amounts to
the debenture holders who are entitled thereto, as soon as possible after proofs and
certifications are submitted to the Trustee’s complete satisfaction concerning their right to
these amounts, and less the Trustee’s costs and commissions at its customary rate for the
same time.

- 23 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	31.	 	Miscellaneous
	 
	 	 	Disagreements between the parties to this Trust Deed will be adjudicated exclusively by the
court in Tel Aviv-Jaffa, which is vested with material jurisdiction.
	 
	32.	 	Addresses
	 
	 	 	The parties’ addresses are as set out in the preamble to this Deed, or any other address of
which appropriate written notice is served by one party to the other.
	 
	33.	 	Stamping
	 
	 	 	Stamping of this Deed, if and to the extent required by law, will be done by the Company, at
its expense.

In witness whereof the parties have set their hand hereto:

	 	 	 
	( - )
	 	( - )
	 
	 
	 	 
	Cellcom Israel Ltd.
	 	Hermetic Trust (1975) Ltd.

I the undersigned, Erez Yitzhaki, Adv., hereby certify that this Trust Deed was signed by Cellcom
Israel Ltd. in accordance with its memorandum and articles, through Messrs. Tal Raz and Oren
Lieder.

	 	 	 	 	 	 	 
	 

	 	 	 	( - )
	 	 
	 
	 

	 	 	 	 

Erez Yitzhaki, Adv. 

License No. 22443	 	 

- 24 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

ADDENDUM A – DEBENTURES

 

CELLCOM ISRAEL LTD.

Debentures (Series B)

A series of registered debentures (series B) unlimited in amount, of NIS 1 principal amount each,
payable in 5 equal annual installments, on January 5 of each calendar year, from January 5, 2013 to
January 5, 2017 (inclusive), bearing 5.30% annual interest and linked principal and interest to the
Consumer Price Index for November 2005 and.

Registered Debentures

Certificate number                     

Total principal amount of the debentures in this certificate NIS                     

Registered owner of the debentures in this certificate
                    

	1.	 	This certificate witnesses that Cellcom Israel Ltd. (“the Company”) will pay on January 5 of
each calendar year, from January 5, 2013 to January 5, 2017 (inclusive), to whoever is
registered in the Company’s register of debenture holders as the holder of the debentures in
this certificate, 20% of the principal amount of this debenture. The unpaid principal of the
debenture will be linked to the Consumer Price Index for November 2005 and will bear 5.30%
annual interest, all in accordance with the terms of the Trust Deed, the debenture certificate
and the terms set forth in the back of the page.
	 
	2.	 	The debentures of this series are issued in accordance with a trust Deed dated December 21,
2005, drawn up and signed between the Company of the one part and Hermetic Trust (1975) Ltd.,
as the Trustee, of the other part (“the Trust Deed”).
	 
	3.	 	The debenture is issued subject to the terms set forth in the back of the page and to the
terms of the Trust Deed.

 

Cellcom Israel Ltd.

Date:                     

- 25 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

TERMS SET FORTH IN THE BACK OF THE OAGE

	1.	 	General
	 
	 	 	In this Debenture (Series B), the terms below will have the meanings below, unless another
meaning is implied by the context:

	 	 	 	 	 
	 

	 	“the Company” -
	 	Cellcom Israel Ltd.
	 
	 	 	 	 
	 

	 	“the Trust Deed” -
	 	The Trust Deed dated December 21, 2005 between the Company
and Hermetic Trust (1975) Ltd. in connection with the issue
of the Debentures (Series B).
	 
	 	 	 	 
	 

	 	“debentures” or
“Debentures (Series B)”
-
	 	A series of registered debentures (series B) unlimited in
amount, of NIS 1 principal amount each, issued by the
Company pursuant to the Trust Deed.
	 
	 	 	 	 
	 

	 	“the Trustee”
	 	Hermetic Trust (1975) Ltd. or any trustee replacing it, in
accordance with the terms of the Trust Deed.
	 
	 	 	 	 
	 

	 	“principal” or
“principal amount” or
“debenture principal” -

	 	The unpaid principal amount of the debentures in circulation.

	 
	 	 	 	 
	 
	 	 	 	 
	 

	 	“the register” -
	 	The register of holders of debentures of the Company, in
which will be recorded all the holders of the debentures.
	 
	 	 	 	 
	 

	 	“debenture holder” -
	 	The person whose name is written at the time in question in
the register as the holder of the debenture, and in the case
of several joint holders – the joint holder whose name is
written first in the register.
	 
	 	 	 	 
	 

	 	“the Securities Law” -
	 	The Securities Law, 5728-1968 and the regulations thereto as
in force from time to time.
	 
	 	 	 	 
	 

	 	“the known index” -
	 	The last known index.
	 
	 	 	 	 
	 

	 	“the base index” -
	 	The index published on December 15, 2005 for the month of
November 2005.
	 
	 	 	 	 
	 

	 	“the payment index” -
	 	The known index on the date of any payment on account of the
principal or the interest.
	 
	 	 	 	 
	 

	 	“Consumer Price Index”
or “index” -
	 	The price index known as “the Consumer Price Index”
including fruits and vegetables, published by the Central
Bureau of Statistic and Economic Research, including the
same index even if published by another official
organization or institution, and including any other index
replacing it, whether built on the same data as the existing
index or not. If the index is replaced by another index

- 26 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	 	 
	 

	 	 	 	published by an organization or institution as aforesaid,
and such organization or institution has not set the ratio
between such other index and the replaced index, said ratio
shall be set by the Central Bureau of Statistics. If such
ratio is not set as stated, then the Trustee in consultation
with economic experts to be chosen by it will set the ratio
between the other index and the replaced index;
	 
	 	 	 	 
	 

	 	“the issue date” -
	 	December 22, 2005.
	 
	 	 	 	 
	 

	 	“business day” -
	 	Any day on which most of the big banks in Israel as well as
the Stock Exchange clearinghouse are open to the public for
the execution of transactions.
	 
	 	 	 	 
	 

	 	“the Stock Exchange” -
	 	The Tel Aviv Stock Exchange Ltd.
	 
	 	 	 	 
	 

	 	“sum of net financial
Indebtedness” known on
any date –
	 	(a) the sum of the Company’s indebtedness in respect of
credit taken from financial institutions, institutional
investors and other holders of debentures of the Company,
less (b) short-term investments of the Company, including
its cash balances and its deposits with financial
institutions, all as stated in the Company’s last financial
statements, audited or reviewed by the Company’s auditors
and certified by the Company’s board of directors prior to
that date;
	 
	 	 	 	 
	 

	 	“EBITDA” in any period –
	 	The Company’s earnings before depreciation expenses,
financing, taxes and other deductions, all as stated in the
Company’s financial statements for that period, audited or
reviewed by the Company’s auditors and certified by the
Company’s board of directors.

	 	 	The debentures form an integral part of the Trust Deed, and in case of a contradiction
between them, the provisions of the Trust Deed shall prevail.
	 
	2.	 	Pari Passu and No Liens
	 
	 	 	The debentures will stand pari passu with respect to the amounts payable on them, without any
priority of one debenture from this series over another.
	 
	 	 	The Company undertakes not to create liens on its assets, of any nature or kind, for as long
as the Debentures (Series B) have not been fully paid, excluding a fixed lien on assets to
secure credit enabling the purchase of those assets.
	 
	 	 	The debentures are not secured by any collateral.

- 27 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	3.	 	Payment of the Debenture Principal
	 
	 	 	The principal will be paid in 5 equal annual installments, on January 5 of each calendar
year, from January 5, 2013 to January 5, 2017 (inclusive), plus index-linkage differences, as
provided in clause 5 below. If the principal payment date falls on a non-business day, the
payment date will be deferred to the first business day thereafter, and no interest will be
paid in respect of such deferral.
	 
	4.	 	Payment of the Interest
	 
	 	 	The unpaid balance of the debenture principal will bear interest at a rate of 5.30% per annum
(“the interest”). The interest will be linked to the Consumer Price Index, in accordance with
the linkage conditions, as provided in clause 5 below.
	 
	 	 	Interest will be paid on January 5 of each of the years 2007 to 2017 (inclusive), for the
twelve-month period ended on the last day before every such date (“the interest period”),
except for the first interest period, in respect of which interest (calculated on the basis
of 365 days) will be paid pro rata for the period beginning on the issue date and ending on
January 4, 2007.
	 
	 	 	It is hereby clarified that the first interest payment will be made on January 5, 2007.
Accordingly, the first interest will be at a rate of 5.503%.
	 
	 	 	The last interest payment will be made on January 5, 2017, together with the last payment of
the unpaid principal of the debentures in circulation and against the return of the debenture
certificate to the Company.
	 
	 	 	If the interest payment date falls on a non-business day, the payment date will be deferred
to the first business day thereafter, and no interest will be paid in respect of such
deferral.
	 
	 	 	The Company will deduct from the interest payment any amount it is required to deduct at
source, if at all, in accordance with any law.
	 
	 	 	Subject as provided in clause 7 below, if the Company delays more than five business days
after the appointed day for paying any amount on account of the principal and/or interest as
aforesaid (“the amount in arrears”), such amount will bear, in respect of the entire period
of arrears from the day appointed for payment, arrears interest at the interest rate on
Debentures (Series B) specified at the head of this clause plus 2%, all on an annual basis
(“the arrears interest”). To remove doubt, it is hereby clarified that during the arrears
period, arrears interest will be paid alone (and not in addition to the interest as defined
above). In such case, the Company will notify the holders and will submit to the Stock
Exchange without delay a report indicating the exact interest rate including the arrears
interest.
	 
	5.	 	Principal and Interest Linkage Conditions
	 
	 	 	The debenture principal and the interest thereon will be linked to the Consumer Price Index
in the following manner: If it becomes apparent on the date of any payment on

- 28 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	account of the debenture principal and/or the interest thereon that the payment index has
increased compared to the base index, the Company will pay such amount of the principal
and/or interest increased in proportion to the rate of increase of the payment index over the
base index; however, if it becomes apparent that the payment index is the same as or lower
than the base index, the payment index will be the base index.
	 
	6.	 	Persons Entitled to Principal and Interest Payments

	 	6.1	 	Any payment on account of the principal and/or interest will be paid to the
debenture holders whose names are recorded in the register at the end of the day of
December 24, immediately preceding the due date of any principal and/or interest payment
(hereinabove and hereinafter: “the determining day”), except for the final payment which
will be made against the delivery of the debenture certificate to the Company at least
five business days before the date set for the final payment, at the Company’s
registered office and/or at any other place of which the Company will give notice.
	 
	 	6.2	 	The payment will be made to the entitled persons by check or bank transfer,
crediting the bank account of the persons whose names appear in the register as the
holders of the debentures, the details of which will be provided in writing to the
Company in good time, and in any case not later than 12 days before the date of the
payment on account of the principal and/or interest.
	 
	 	6.3	 	If the person entitled to a payment from the Company fails to provide the details
of the bank account in good time, as aforesaid, the Company will send a check by
registered post to his last address written in the register. The sending of a check to
the entitled person by registered post as stated will be deemed in all respects as
payment of the amount specified in the check on the date of dispatch thereof by post,
provided it is paid upon proper presentation for collection.
	 
	 	6.4	 	A holder wishing to change his instructions concerning the manner of payment, as
stated above, may do so in a notice sent by registered letter to the Company, However,
the Company will comply with such instruction only if it reached its registered office
at least 15 days before the due date of any payment under the debenture. If the notice
is received by the Company after such time, the Company will act in accordance therewith
only with respect to payments with a due date after the payment date immediately
following the day of receipt of the notice.

7. Non-Payment for a Reason Not Dependent on the Company

	 	7.1	 	Any amount due to the debenture holder which is not actually paid on the date set
for its payment for a reason not dependent on the Company, whereas the Company was
prepared to make the payment, will stop bearing interest and linkage differences from
the time set for its payment, and the debenture holder will be entitled solely to the
amounts to which he would have been entitled on the day set for making that payment on
account of the principal, interest and linkage.

- 29 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	7.2	 	The Company will deposit with the Trustee, within 15 business days from the date
set for such payment, the amount of the payment that was not made for a reason not
dependent on it, and said deposit will be deemed as the absolute discharge of that
payment, and in case of the discharge of all the amounts due on the debenture, also as
the redemption of the debenture. The Company will notify the holders entitled to such
amount of its deposit with the Trustee. The notice will be sent to the address of the
entitled holder written in the register at the time, not later than at the end of 7
business days from the deposit with the Trustee.
	 
	 	7.3	 	The Trustee will invest any such amount in trust accounts, in its name and to its
order on behalf of those debenture holders, and will invest it in permissible
investments under the laws of the State of Israel and the provisions of the Trust Deed,
all as it deems fit and subject to any law and to the provisions of clause 30 of the
Trust Deed. If the Trustee does so, it will owe the persons entitled to those amounts
only the proceeds obtained from the realization of the investments, less related costs,
management costs of the trust account and any mandatory payments applying to the trust
account and/or to the investment, and it will pay said proceeds to the entitled persons
against presentation of the proofs required by it, to its complete satisfaction.
	 
	 	7.4	 	The Trustee will hold these moneys and invest them in the aforesaid manner until
the end of one year from the final redemption date of the debentures. After this date,
the Trustee will transfer the amounts accumulated with it (including the earnings
derived from their investment), less its fee and costs, to the Company, which will hold
these amounts in trust on behalf of the entitled persons. The Company will confirm to
the Trustee in writing that it is holding the aforesaid amounts which were accepted by
it in trust on behalf of the entitled persons, and it will indemnify the Trustee for
damage of any kind to it caused by the transfer of the moneys as aforesaid, provided the
Trustee acted reasonably. The Company will hold these moneys in trust on behalf of the
entitled debenture holders during a further six years from the day on which it received
them from the Trustee. Moneys that have not been demanded from the Company by a
debenture holder by the end of seven years from the final redemption date of the
debentures, will pass to the Company, which will be entitled to use the remaining moneys
for any purpose whatsoever.

8. Transfer of the Debentures

	 	8.1	 	For as long as the Debentures (Series B) have not been listed on the Stock
Exchange, they may be transferred only to an investor as this term is defined in the
First Schedule according to section 15A(b)(1) of the Securities Law, or to the Company
or to a subsidiary of the Company, all – subject to the restrictions in law. The
debentures are transferable in respect of any sum of principal amount, provided it is in
whole new shekels. Any transfer of a debenture will be done on the basis of a transfer
instrument in the accepted wording, duly signed by the

- 30 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	registered holder or his lawful representatives, to be delivered to the Company at
its registered office together with the certificate of the transferred debenture and
any other proof required by the Company concerning the transferor’s right to
transfer the debenture.
	 
	 	 	 	Clause 8.1 above will not apply to debentures listed in the trading system for
institutional investors operated by the Stock Exchange, for as long as they are so
listed.
	 
	 	8.2	 	If stamp tax or another mandatory payment applies to the debenture transfer
instrument, proof of the payment thereof by the applicant will be provided to the
Company’s satisfaction.
	 
	 	8.3	 	In case only part of the sum of principal amount of a debenture is transferred,
the debenture certificate will first be split as provided in clause 9 below into the
appropriate number of debenture certificates, such that the total of all the principal
amounts specified therein will be equal to the principal amount specified in the
original debenture certificate.
	 
	 	8.4	 	Following compliance with all these conditions, the transfer will be registered
in the register of the debenture holders.
	 
	 	8.5	 	All the costs and commissions entailed in the transfer will be borne by the
transfer applicant.
	 
	 	8.6	 	Subject to the provision of clause 8.7 below, the Debentures (Series B) will not
be listed on any stock exchange. Subject to the provisions of the law and to the Stock
Exchange rules, the Company will register the debentures in the name of the Registration
Company of Israel Discount Bank Ltd., and within 30 days from the date of their issuance
they will be registered at the Stock Exchange clearinghouse, which will provide clearing
services for the debentures, and they will also be listed in the computerized trading
system for institutional investors operated by the Stock Exchange (“listing in the
institutional continuous trading system”). Failure to list the debentures in the
institutional continuous trading system as aforesaid owing to an act or omission of the
Company shall be deemed a fundamental breach by the Company. It is hereby clarified that
subject to the provisions of the law and the Stock Exchange rules, other than an
institutional investor as defined in the First Schedule to the Securities Law,
5728-1968, no one may trade in the debentures in the framework of the computerized
trading system for institutional investors as stated.
	 
	 	8.7	 	The Company undertakes, subject to the provisions of any law and the Stock
Exchange rules, to list the debentures on the Stock Exchange on the basis of a
prospectus not later than June 30, 2006 (“the determining date for listing”). If the
debentures are not listed on the Stock Exchange by the determining date for listing,
then –

- 31 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	8.7.1	 	The Company will notify the holders not later than July 5,
2006 that the Debentures (Series B) were not listed as stated. The debentures
will continue to be traded in the computerized trading system for institutional
investors, and the debenture holders will have the right (“the option”), as a
sole relief, to sell to the Company the Debentures (Series B) held by them, as
set out in this clause 8.7.
	 
	 	8.7.2	 	Any holder wanting to exercise the option (“the exerciser”)
will notify the Company in writing (“exercise notice”), not later than July 31,
2006, of his wish to exercise the option, specifying the total principal amount
of the Debentures (Series B) which he wishes to sell to the Company within the
exercise (“the value sold”), and if he is a holder whose name is not listed in
the register, he will attach to his notice a confirmation by the Stock Exchange
member attesting to his ownership of the value sold. The exerciser will attach
to the exercise notice a certificate of exemption from deduction of tax at
source, if such exists.
	 
	 	8.7.3	 	Not later than one business day before September 28, 2006
(“the first exercise date”), each exerciser will sell to the Company, in an
off-floor transaction, one-half of the value sold indicated in his exercise
notice, and where said one-half is not a sum of principal amount in whole new
shekels, the sum ofprincipal amount will be rounded up to the nearest new
shekel (“the half”). In return, the Company will pay the exerciser, on the
first exercise date, within off-floor transaction, the outstanding balance of
the unpaid principal of the half, plus linkage differences, as well as the
unpaid interest (together with linkage differences), to which the exerciser is
entitled for the half up to the first exercise date according to the terms of
the Debentures (Series B) and which was not paid by them.
	 
	 	8.7.4	 	Not later than one business day before March 29, 2007 (“the
second exercise date”), each exerciser will sell to the Company the value sold
indicated in his exercise notice less the half (“the balance of the value
sold”). In return, the Company will pay the exerciser, on the second exercise
date, within the off-floor transaction, the outstanding balance of the unpaid
principal of the balance of the value sold, plus linkage differences, as well
as the unpaid interest (together with linkage differences), to which the
exerciser is entitled for the balance of the value sold up to the second
exercise date according to the terms of the Debentures (Series B) and which was
not paid by them.
	 
	 	8.7.5	 	Tax at source will be deducted from the amounts paid by the
Company under this clause, where this is required by law.
	 
	 	8.7.6	 	The exercise notice submitted to the Company may not be
canceled or modified. It is hereby clarified that the interest which the
Company under the terms of the Debentures (Series B) during the period between
July 31,

- 32 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	2006 and the first exercise date and the second exercise date, as the case
may be, will be paid to whoever will be the holders of Debentures (Series B)
on the determining date for the payment of said interest.
	 
	 	8.7.7	 	The Company will notify the holders concerning the manner in
which the half and the balance of the value sold should be transferred to it,
not later than September 15, 2006.
	 
	 	8.7.8	 	If the sum of the value sold by all the exercisers according
to the exercise notices received by the Company will not be less than 90% of
the total principal amount of the Debentures (Series B) in circulation on July
31, 2006, then subject to the provisions of the law and the Stock Exchange
rules, the Company will be entitled to serve notice of the early redemption of
the Debentures (Series B) to take place on April 1, 2007 (“the early redemption
date”). Where the Company so chose –

	 	8.7.8.1	 	The debenture holders will be served a notice in this regard not
later than March 1, 2007, but not earlier than October 1, 2006. On the
date of service of the notice the Company will submit a report to the
Stock Exchange in which it will indicate the exact rate of interest to
be paid to the holders on the early redemption date, calculated on the
basis of 365 days in a year.
	 
	 	8.7.8.2	 	On the early redemption date the Company will pay the holders the
balance of the unpaid principal and interest (together with linkage
differences) to which the holders are entitled up to the early
redemption date according to the terms of the Debentures (Series B).

9. Splitting of Debenture Certificates

	 	9.1	 	Every debenture certificate may be split into a number of debenture certificates,
such that the total of all the principal amounts specified therein is equal to the
principal amount specified in the debenture certificate in respect of which the split is
requested. A split will be executed against the delivery of the relevant certificate at
the Company’s registered office for the execution thereof.
	 
	 	9.2	 	Splitting of debenture certificates as stated will be done on the basis of a
split application signed by the holder of those debenture certificates or his legal
representatives, to be submitted to the Company at its registered office together with
the debenture certificate in respect of which the split is requested.
	 
	 	9.3	 	The split will be executed within fourteen days from the end of the month in
which the certificate was delivered at the Company’s registered office. The new
debenture certificates issued following the split will each be for a principal amount
sums in whole shekels.

- 33 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	      9.4	 	All the costs entailed in the split, including stamp tax and other imposts, if
any, will be borne by the split applicant.

	10.	 	Purchase of Debentures by the Company and Related Companies
	 
	 	 	The Company reserves the right to purchase at any time debentures from this series, at any
price deemed appropriate by it, without derogating from the duty of payment of the balance of
the unpaid debentures in circulation. The purchase of the debentures by the Company will be
deemed as the redemption of those debentures, which will lapse; and if they were listed, then
they will also be canceled and delisted from trade in the trading system for institutional
investors or on the Stock Exchange, as the case may be, and the Company will not be allowed
to reissue them. It is hereby clarified that if such debentures are purchased by a subsidiary
or by an included company or by a related company of the Company (as this term is defined in
the Securities Law) or by the controlling shareholder in the Company, this shall not be
deemed as the redemption of the debentures that were purchased by the subsidiary, the
included company or the controlling shareholder as aforesaid; however, for as long as the
debentures are held by the subsidiary, the included company, the related company or the
controlling shareholder as aforesaid, they will not confer on their holders the right to vote
in general meetings of the debenture holders or taken into account for the purpose of
determining the presence of a quorum, except if any one of the above is an investor from
among those enumerated in the First Schedule to the Securities Law (in the matter of section
15A(b)(1) of the law), who is not investing on its own behalf (“related institutional
investor”), in which case its vote will be taken into account. It is hereby clarified that a
subsidiary, an included company, a related company or the controlling shareholder as
aforesaid not being related institutional investors will be entitled to participate in such
meetings, without a voting right.
	 
	 	 	The Company will notify the Trustee in any case of the purchase of debentures from this
series by it or by a subsidiary or by an included company or by the controlling shareholder
in the Company (upon learning thereof).
	 
	11.	 	Additional Allotments of Debentures from This Series and Other Debentures

	 	11.1	 	The Company will be entitled, from time to time, at its sole discretion, to issue
additional Debentures (Series B), without need of the consent of the Trustee or of the
holders of Debentures (Series B) then in circulation (“the additional Debentures (Series
B)”). Without derogating from the generality of the above, the Company will be entitled
to issue the additional Debentures (Series B) at the same price or at a higher or lower
price than the price at which earlier debentures from series B were issued.
	 
	 	 	 	All the terms and provisions applying to the Debentures (Series B) will apply also
to the additional Debentures (Series B); to remove doubt, it is clarified that: (a)
the principal of the additional Debentures (Series B) will be paid, on every date of
payment on account of the principal, proportionally to the remaining number of
principal payments; and (b) the holders of the additional Debentures (Series B)

- 34 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	will not be entitled to interest for interest periods that ended prior to their
allotment date.
	 
	 	 	 	The Company will notify the Trustee, and the Trustee will notify the debenture
holders, concerning the issuance of additional Debentures (Series B).
	 
	 	11.2	 	To remove doubt, it is clarified that the Company reserves the right to issue at
any time additional debentures series or other securities, with preferred, equal or
inferior rights to the Debentures (Series B), whether they confer or do not confer a
right of conversion into shares of the Company and upon such redemption, interest and
linkage terms and other terms as the Company deems fit and subject to the provisions of
clause 2 above, all as the Company deems fit, at its discretion, without need of the
consent of the Trustee or of the holders of Debentures (Series B) then in circulation.

	12.	 	Dividend Distribution
	 
	 	 	For as long as the debentures have not been listed on the Stock Exchange – the Company will
not distribute a dividend if the Company’s known net financial indebtedness on the
distribution date exceed three times the accumulated EBITDA in the four last calendar months
included in the Company’s financial statements certified by its board of directors prior to
the distribution date.
	 
	13.	 	Register of the Debenture Holders
	 
	 	 	The Company will maintain and manage in its registered office the register, in which it will
record the names and addresses of the debenture holders, the numbers and principal amount of
the debentures held by them. All transfers of title to the debentures in accordance with the
terms of the debentures and the Trust Deed will be registered in the register. The Trustee
and any debenture holder will be entitled to inspect the register.
	 
	 	 	The Company will not be obligated to record in the register any notice concerning a trust,
pledge, lien or any equitable right, claim or offset or other right in connection with the
debentures. It is expressly clarified that the Company will recognize solely the title of the
person in whose name the debentures are registered in the register, provided the legal heirs,
administrators or executors of the registered owner and any person becoming entitled to the
debentures by reason of the bankruptcy of the registered owner (and in the case of a
corporation – by reason of its liquidation), will be entitled to be registered as the owner
thereof, but only after providing proof to the Company’s satisfaction of their right to be so
registered.
	 
	14.	 	Representation by the Trustee
	 
	 	 	The Trustee will represent the debenture holders in any matter arising from the Company’s
obligation toward them according to or in connection with the debentures, and the debenture
holders hereby grant the Trustee an irrevocable power of attorney to act in their name and
stead in every such matter. To remove doubt, the aforesaid shall not

- 35 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	derogate from the right of the debenture holders to dismiss the Trustee in accordance with
the provisions of the law and the Trust Deed. If the Trustee is dismissed aforesaid, the new
trustee will be the attorney under this clause 14.
	 
	15.	 	Compromise and/or Alterations to the Debenture Terms
	 
	 	 	No alteration, waiver and/or compromise in anything pertaining to the terms of the debentures
will be valid, unless made in accordance with the provisions of the Trust Deed.
	 
	16.	 	General Meetings of the Debenture Holders
	 
	 	 	General meetings of the debenture holders will convene and proceed in the manner provided in
Addendum B to the Trust Deed.
	 
	17.	 	Replacement of Debenture Certificates
	 
	 	 	If a debenture share becomes worn or is lost or destroyed, the Company may issue in its stead
a new debenture certificate upon the same terms, subject to such proof, indemnity and
coverage of the expenses incurred by the Company in verifying the title as the Company deems
fit, provided that in the case of wear, the worn debenture certificate is returned to the
Company before the new certificate is issued. Stamp tax and other imposts as well as other
expenses entailed in the issuance of the new certificate will be borne by the applicant for
such certificate.
	 
	18.	 	Notices
	 
	 	 	Except those cases in which this debenture provides otherwise, any notice by the Company
and/or the Trustee to the debenture holders will be served in a registered letter sent to the
debenture holder’s last address appearing in the register, and any notice sent as stated will
be deemed to have been received by the debenture holder at the end of three days from the day
of its delivery at the post office.
	 
	 	 	The Trustee will send the Company copies of notices and invitations served by it to the
debenture holders. Likewise, the Company will send the Trustee copies of notices and
invitations served by it to the debenture holders.
	 
	 	 	However in the event that the debentures are listed, including in the computerized system for
trade in institutional securities operated by the Stock Exchange, a notice by the Company
and/or the Trustee to the debenture holders may, instead of being sent by registered post as
stated above, be served to the registration company and by publication in at least two widely
circulated daily newspapers published in Israel in the Hebrew language, and in such case, the
day of publication will be deemed as the day of receipt of the notice by the debenture
holders.

- 36 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

ADDENDUM B: GENERAL MEETINGS OF THE DEBENTURE HOLDERS

1. Convening a General Meeting

	 	1.1	 	The Company may convene general meetings of the debenture holders. The notice of
invitation will be sent to the Trustee and to the debenture holders, setting out the
time, day and place at which the meeting is to take place and the business which is to
be conducted therein.
	 
	 	1.2	 	The Trustee may convene general meetings of the debenture holders. The notice of
invitation will be sent to the Company and to the debenture holders, setting out the
time, day and place at which the meeting is to take place and the business which is to
be conducted therein.
	 
	 	1.3	 	The Company or the Trustee shall be obligated to convene a general meeting of the
debentures upon the written requisition of holders representing at least ten percent
(10%) of the unpaid balance of the principal of the debentures in circulation. In such
case, the Trustee or the Company, as the case may be, will be entitled to receive from
the debenture holders requesting the meeting reimbursement of the reasonable costs
entailed in convening the meeting.
	 
	 	1.4	 	Notice of at least fourteen (14) days will be given concerning a general meeting
in which it is proposed to pass an ordinary resolution or which is being convened for
the presentation of a report. Notice of at least twenty one (21) days will be given
concerning a general meeting in which it proposed to pass a special resolution.
Notwithstanding the aforesaid, the Trustee may shorten the period of such notice if it
is of the opinion that the rights of the debenture holders will be prejudiced by the
postponement of the meeting.
	 
	 	1.5	 	Any notice by the Company and/or the Trustee to the debenture holders concerning
the convening of a meeting will be served by registered post to each of the debenture
holders according to their last address appearing in the register, and any notice sent
as stated will be deemed to have been received by the debenture holder at the end of
three (3) days from the day of its dispatch by post.
	 
	 	 	 	However in the event that the debentures are listed on the Stock Exchange, including
in the computerized system for trade in institutional securities operated by the
Stock Exchange, a notice by the Company and/or the Trustee to the debenture holders
concerning the convening of a meeting may, instead of being sent by registered post
as stated above, be served by publication in at least two widely circulated daily
newspapers published in Israel in the Hebrew language, and in such case, the day of
publication will be deemed as the day of receipt of the notice by the debenture
holders.
	 
	 	1.6	 	Every general meeting will be held at the Company’s registered office or at
another address of which the Company will give notice or – where the meeting is

- 37 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	being convened by the Trustee – at an address of which the Trustee will give notice.
	 
	 	1.7	 	No resolution lawfully passed in a meeting of the debenture holders will be
invalidated where, due to an oversight, notice thereof was not served to the holders of
less than 10% of the balance of the unpaid principal of the debentures in circulation,
or where notice thereof was not received by such holders.

	2.	 	Chairman of the Meeting
	 
	 	 	The meeting will be presided over by the Trustee or by another person appointed by the
Trustee to serve as chairman of the meeting. In case the Trustee (or the person appointed by
it for this purpose) is not present at the meeting within half an hour from the time set for
the commencement thereof, the debenture holders present at the meeting will choose one of
their number to serve as chairman of the meeting.
	 
	3.	 	Quorum

	 	3.1	 	Two debenture holders at least, representing at least twenty percent (20%) of the
unpaid balance of the principal of the debentures in circulation, present at a meeting
in which it is proposed to pass an ordinary resolution or which has been convened for
the presentation of a report will be deemed a quorum.
	 
	 	3.2	 	Two debenture holders at least, representing at least fifty percent (50%) of the
unpaid balance of the principal of the debentures in circulation, present at a meeting
in which it is proposed to pass a special resolution will be deemed a quorum.
	 
	 	3.3	 	If a quorum is not present within half an from the time set for the meeting, the
meeting will be adjourned to the same day in the next week (and where such day is not a
business day, to the first business day immediately thereafter), at the same time and
place, or to another day, time or place, if noted in the original invitation to the
meeting, without need of an additional notice to the debenture holders. At an adjourned
meeting, if a quorum is not present within half an hour from the time set for the
meeting, the meeting will be held with any number of participants. Notwithstanding the
aforesaid, in the case of a general meeting in which it is proposed to pass a special
resolution, the adjourned meeting will not be held unless debenture holders representing
at least ten percent (10%) of the unpaid balance of the principal of the debentures in
circulation are present.
	 
	 	3.4	 	The chairman of a general meeting may, with the consent of debenture holders
present at a meeting in which there is a quorum, and representing more than fifty
percent (50%) of the unpaid balance of the principal represented by the holders present
at the meeting, adjourn the meeting, and he shall adjourn the meeting if so directed by
such majority. Only business that was on the agenda of the original meeting and that was
not concluded or not begun may be transacted at an adjourned meeting.

- 38 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

4. Voting Rights

	 	4.1	 	Votes in any meeting of the debenture holders will be conducted on a poll.
	 
	 	4.2	 	In a vote, each holder present in person or by proxy will have one vote for every
NIS 1 of the unpaid balance of the debenture held by him. In the case of joint holders,
only the vote of the holder from among them whose name appears first in the register of
the debenture holders and who proposes to vote, in person or by proxy, will be counted.
	 
	 	4.3	 	The chairman of the meeting will not have a further or a casting vote.
	 
	 	4.4	 	The Trustee may participate in a meeting, without a voting right.
	 
	 	4.5	 	The debenture holders will be entitled to participate and vote in a meeting in
person or by proxy, as set out below.
	 
	 	4.6	 	Any instrument appointing a voting proxy (“instrument of appointment”) will be
signed by the appointer or by an attorney authorized to do so in writing, or, where the
appointer is a corporation – in an instrument duly signed by the corporation or by its
authorized representative.
	 
	 	4.7	 	The instrument of appointment, and the power of attorney based on which the
instrument of appointment was signed (if at all), or a copy thereof certified to the
Company’s satisfaction, will be deposited at the Company’s office or at the place
appointed for holding the meeting not less than forty eight (48) hours before the time
set for the meeting at which the person named in the instrument of appointment proposes
to vote. However, the chairman of the meeting may waive this demand for all the
participants in any meeting and accept the aforesaid instruments of appointment and
powers of attorney at the start of the meeting.
	 
	 	4.8	 	An instrument of appointment will be valid also for any adjourned meeting of the
meeting to which it refers, unless stated otherwise in the instrument of appointment.
	 
	 	4.9	 	A vote by virtue of an instrument of appointment will be valid notwithstanding
the death of the appointer, or the revocation of the power of attorney on the basis of
which the instrument of appointment was issued, or the transfer of the right under the
debenture in respect of which the instrument of appointment was issued, unless a written
notice concerning the death, revocation or transfer was received at the office or by the
chairman of the meeting before the vote.

	5.	 	Resolutions in General Meeting

	 	5.1	 	Subject to clauses 5.2 and 6 below, all resolutions in general meeting will be
passed as ordinary resolutions. An ordinary resolution will be carried by a simple
majority of the participating votes (excluding abstainers). A special resolution

- 39 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	 	 	(“special resolution”) will be carried by a majority of seventy five percent (75%) of
the participating votes (excluding abstainers).
	 
	 	 	 	The required majority in a resolution to dismiss the Trustee is as stated in clause 7
below.
	 
	 	5.2	 	Resolutions on the matters listed below will be passed by the general meeting
solely as a special resolution:

	 	5.2.1	 	An alteration in the terms of the Trust Deed (including an
alteration in the terms of the debentures), where this requires a resolution of
the general meeting of the debenture holders, as provided in clause 24 of the
Trust Deed.
	 
	 	5.2.2	 	A compromise with the Company in connection with any right or
claim of the debenture holders or any of them, or of the Trustee, or any
settlement with the Company in connection with the rights of the debenture
holders or the rights of the Trustee under the Trust Deed or according to the
terms of the debentures, and inter alia a waiver of any right or claim of the
Trustee and/or of the debenture holders against the Company, in accordance with
and subject to the provisions of clause 24 of the Trust Deed.
	 
	 	5.2.3	 	Any other matter which by the terms of the debentures or the
Trust Deed requires a special resolution of the general meeting of the debenture
holders.
	 
	 	5.2.4	 	A call for immediate payment on the debentures.
	 
	 	5.2.5	 	Issuance of instructions to the Trustee.

	 	5.3	 	It is hereby clarified that debenture holders being a controlling shareholder in
the Company, companies controlled by controlling shareholder in the Company and related
and included companies of the Company, as these terms are defined in the law, will not
be counted in the quorum or in the vote of a general meeting convened for the purpose of
passing an ordinary or special resolution, excluding any of the above being a related
institutional investor (as this term is defined in clause 10 of the Terms set forth in
the back of the page), whose vote will be taken into account.
	 
	 	5.4	 	In every general meeting of the debenture holders, minutes will be made of all
the proceedings and resolutions in the meeting. Any minutes signed by the chairman of a
meeting in which resolutions were passed and deliberations took place was transacted,
will be prima facie proof of the matters written therein, and unless proven otherwise,
any resolution passed in such a meeting will be deemed to have been passed lawfully.

- 40 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	 	5.5	 	A person or persons appointed by the Trustee or by the Company and any other
person or persons so authorized by the Company, may be present in a general meeting of
the debenture holders (without a voting right).

6. Dismissal of the Trustee

	 	6.1	 	An invitation to a general meeting of the debenture holders in which it is
proposed to pass a resolution to dismiss the Trustee will be served in the same way as
an invitation to a meeting in which it is proposed to vote on a special resolution.
	 
	 	6.2	 	The required majority in a resolution to dismiss the Trustee is the votes of
debenture holders representing at least fifty percent (50%) of the unpaid balance of the
principal of all the debentures then in circulation.

*****************

- 41 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

ADDENDUM C TO THE TRUST DEED SIGNED ON DECEMBER 21, 2005

BETWEEN CELLCOM ISRAEL LTD.

AND HERMETIC TRUST (1975) LTD.

The Company will pay fees to the Trustee for its services in accordance to the debenture as
follows:

	1.	 	For the first trust year, beginning on the date of the Trust Deed and ending 12 months
thereafter, the sum of NIS 15,000. The aforesaid payment shall be payable within 30 days from
the end of the month in which the Company receives from the Trustee an invoice in respect of
this payment. The Trustee will be entitled to forward to the Company an invoice immediately
after the signing of this Trust Deed.
	 
	2.	 	For each of the years starting from the second year (e.g. stating at the lapse of 12 months
from the date of this Deed) in which unpaid Debentures (series B) shall still exist (except
for the first year) an annual fee of NIS 10,000 (the “annual fee”).
	 
	3.	 	The annual fee will be payable to the Trustee within 30 days from the end of the month in
which the Company receives from the Trustee an invoice in respect thereof. The Trustee will be
entitled to issue to the Company an invoice in respect of each year’s annual fee immediately
after the start of each such year. The annual fee will be linked to the index, according to
the rate of increase of the known index on the date of payment of the annual fee compared to
the base index of the debentures.
	 
	4.	 	VAT, if applicable, will be added to the payments due to the Trustee by the provisions of
this clause, and paid by the Company.
	 
	5.	 	The annual fee will be to the Trustee as long as it serves as Trustee under the provisions of
this Deed, even if a receiver and/or the receiver is managing and/or the trust according to
this Deed is managed under court supervision.
	 
	6.	 	If the office of the Trustee is terminated or expires during a trust year (except for the
first trust year), the fee paid in respect of the months in which the Trustee did not serve as
trustee on behalf of the debenture holders will be refunded.
	 
	7.	 	Additionally, the Trustee will be entitled to reimbursement of all its reasonable costs
incurred in the fulfillment of its duties as trustee and /or the authorities given to it
according to this trust deed, provided that with respect to the costs of an expert opinion,
the Trustee notifies the Company in advance of its intention to receive an expert opinion.
	 
	8.	 	Additionally, the Trustee shall be entitled for additional payment for actions in case of the
Company’s noncompliance with its obligations in the debenture or this trust deed or for
actions for the call for immediate payment and for special actions it might need to engage in,
if any, for the fulfillment of its duties according to this deed.

- 42 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

	9.	 	It is hereby agreed that the Trustee shall be entitled to a sum in NIS equal to $120 USA,
according to the representative exchange rate on the actual payment day, for each hour needed
for the aforesaid actions, with the addition of VAT according to the law.
	 
	10.	 	In addition the Trustee shall be entitled for reimbursement of reasonable costs incurred in
the fulfillment of the special actions (in addition to the additional payment as aforesaid).
	 
	11.	 	Additionally the Trustee shall be entitled to payment for the participation in general
meetings of debenture holders in the sum of NIS 250 per (linked to the index as aforesaid in
clause 3), per meeting, with the addition of VAT according to the law. In addition the Trustee
shall be entitled for reimbursement of all reasonable costs incurred in connection to
convening the meetings of debenture holders initiated by it.

- 43 -

 

TRANSLATION FROM HEBREW

THE BINDING VERSION IS THE HEBREW VERSION

ADDENDUM TO THE TRUST DEED

Made and signed in Tel Aviv on February 27, 2006

	 	 	 	 	 
	Between:

	 	Cellcom Israel Ltd.	 	 
	 

	 	P.C. 511930125	 	 
	 

	 	10 Hagavish St., Netanya 42140	 	 
	 

	 	(the “Company”)
	 	of the one part 
	 
	 	 	 	 
	A n d:

	 	Hermetic Trust (1975) Ltd.	 	 
	 

	 	Company no. 51-07051-9	 	 
	 

	 	113 Hayarakon St., Tel Aviv	 	 
	 

	 	(the “Trustee”)
	 	of the other part 

	 	 	 
	Whereas

	 	On December 21 2005 the parties entered into a Trust Deed (“Trust Deed”); and
	 
	 	 
	Whereas

	 	following comments from the Securities Authority the parties wish to amend the provisions of the Trust Deed as set
forth hereunder;

     Therefore, it is hereby agreed, declared and stipulated between the parties as follows:

	1.	 	The interpretation to the terms used in this addendum shall be as defined in the Trust Deed.
	 
	2.	 	In article 11.1 to the Trust Deed, the words “less than ten percent (10%)” shall be replaced
with the words “less than five percent (5%)”.
	 
	3.	 	In article 11.2 to the Trust Deed, the words “ten percent (10%)” shall be replaced with the
words “five percent (5%)”.
	 
	4.	 	In article 11.3 to the Trust Deed, the words “ten percent” shall be replaced with the words
“five percent”.
	 
	5.	 	Article 14 to Addendum A to the Trust Deed shall be deleted.
	 
	6.	 	The remainder of the articles of the Trust Deed shall remain in effect without any change.

In witness whereof the parties have set their hand hereto:

	 	 	 
	( - )
	 	( - )
	––––––––––––––––––––––––––––––––
	 	––––––––––––––––––––––––––––––––
	Cellcom Israel Ltd.
	 	Hermetic Trust (1975) Ltd.

I the undersigned, Liat Menahemi-Stadler, Adv., hereby certify that this Trust Deed was signed by
Cellcom Israel Ltd. in accordance with its memorandum and articles, through Messrs. Amos Shapira
and Tal Raz.

	 	 	 	 	 	 	 
	 

	 	 	 	( - )

 

 

Liat Menahemi-Stadler, Adv.
	 	 
	 

	 	 	 	License No. 18656	 	 

- 44 -EX-10.4

 

EXHIBIT 10.4

CELLCOM ISRAEL, LTD.

2006 SHARE INCENTIVE PLAN

A. NAME AND PURPOSE

1. Name: This plan, as amended from time to time, shall be known as the “Cellcom Israel, Ltd. 2006
Share Incentive Plan”.

2. Purpose: The purpose and intent of the Plan is to provide incentives to employees, directors,
consultants and/or contractors of the Company and its Affiliates, by providing them with
opportunities to purchase Shares, pursuant to a plan approved by the Board which is designed to
enable the Company to issue options and restricted stock units, with respect to Israeli residents,
pursuant to the provisions of either Section 102 or Section 3(9) of the Ordinance, as applicable,
and the rules and regulations promulgated thereunder, as amended from time to time, or any other
tax ruling provided by the tax authorities to the Company, as well as with respect to non-Israeli
residents pursuant to the applicable law in their respective country of residence.

B. DEFINITIONS

“Adoption Date” means the Date of Grant, or any other date of commencement of vesting of an Award
for the purposes of this Plan, that is determined by the Committee
for a given grant of an Award.

“Affiliate” means any company (i) that is a Controlling Shareholder (as such term is defined in
Section 102 of the Ordinance) of the Company, or (ii) of which the Company is a Controlling
Shareholder, or (iii) which has a Controlling Shareholder that is also a Controlling Shareholder of
the Company.

“Awards” means Options and/or RSUs.

“Beneficial Grantee” means the Grantee in respect of whom, an Award held in Trust by the Trustee
was granted.

“Board” means Board of Directors of the Company.

“Cessation of Employment” means the cessation of employment of a Grantee (who was an employee of
the Company on the Date of Grant of any Awards to him or her), with the Company, for any reason.

“Committee” means the Board or a committee appointed by the Board for such purpose, if appointed.

“Companies Law” means the Companies Law 1999.

 

2

“Company” means Cellcom Israel, Ltd., a company organized under the laws of the State of Israel, or
any Affiliate thereof, unless the context otherwise requires.

“Controlling Shareholders” means controlling shareholders of the Company, as such term is defined
in the Ordinance.

“Corporate Transaction” means the occurrence, in a single transaction or in a series of related
transactions, of any one or more of the following events:

     (i) a sale or other disposition of Shares of the Company held by Discount Investment
Corporation Ltd. and its subsidiaries (“DIC”), to a third party that is not an affiliate of
DIC nor its shareholder, resulting in DIC holding of less than 50.01% of the issued share
capital of the Company;

     (ii) a sale or other disposition of all or substantially all, as determined by the Board
in its discretion, of the consolidated assets of the Company and its subsidiaries;

     (iii) a merger, consolidation or similar transaction following which the Company is not
the surviving corporation; or

     (iv) a merger, consolidation or similar transaction following which the Company is the
surviving corporation but the Ordinary Shares of the Company outstanding immediately preceding
the merger, consolidation or similar transaction are converted or exchanged by virtue of the
merger, consolidation or similar transaction into other property, whether in the form of
securities, cash or otherwise.

          Whether a transaction is a “Corporate Transaction” as defined above, shall be finally and
conclusively determined by the Committee in its absolute discretion.

“Date of Grant” means the effective date of the grant of an Award, as detailed in Section 5.1(b)
hereinafter.

“Date of Cessation” means (i) the date on which the employee-employer relationship between the
Grantee and the Company ceases to exist, or (ii) if the Grantee is a contractor or consultant — the
date on which the consulting or contractor agreement between the Grantee and the Company expires,
or the date on which either of the parties to such agreement sends the other notice of its
intention to terminate said agreement, or (iii) if the Grantee is a director — the date on which
the Grantee ceases to serve as a director of the Company.

“Disability” means the inability to engage in any substantial gainful occupation for which the
Grantee is suited by education, training or experience, by reason of any medically determinable
physical or mental impairment that is expected to result in such person’s death or to continue for
a period of six (6) consecutive months or more.

“Exercise Date” means the actual date of exercise of Options.

 

3

“Exercise Price” means the purchase price per Exercised Share, subject to each Option, or the
nominal value per Exercised Share to be paid upon the vesting of an RSU, if applicable.

“Exercised Shares” means Shares received upon exercise of Options (or Rights, if applicable) and/or
vesting of RSUs.

“Grantee” means the person to whom Awards shall be granted under this Plan.

“IPO” means an initial public offering of Shares.

“Notice of Exercise” means a written notice of exercise of an Option, delivered by a Grantee to the
Company.

“Notice of Grant” means a written notice of the grant of an Award.

“102 Awards” means grants of Awards to Israeli employees, directors and office holders of the
Company, other than to a Controlling Shareholder, pursuant to the provisions of Section 102 of the
Ordinance, the 102 Rules, and any other regulations, rulings, procedures or clarifications
promulgated thereunder. Such grants of Awards may be pursuant to (i) a Taxation Route and/or (ii)
Section 102(c) of the Ordinance (“102(c) Awards”).

“102 Rules” means the Income Tax Rules (Tax Relief in Issuance of Shares to Employees), 2003.

“Options” means options to purchase Shares.

“Ordinance” means the Israeli Income Tax Ordinance [New Version], 1961.

“Plan” means this “Cellcom Israel, Ltd. 2006 Share Incentive Plan”, as amended from time to time.

“Representative” means any third party designated by the Company for the purpose of the exercise of
the Options, as provided in Section 9.2 hereinafter.

“Rights” means rights issued in respect of Exercised Shares, including bonus shares but excluding
cash dividends.

“RSUs” means Restricted Stock Units, as described in Section 13 below.

“Shares” means ordinary shares, nominal value of NIS 0.01 each of the Company (subject to an
expected split of the Company’s shares).

“Taxation Route” means the capital gains route under Section 102(b)(2) of the Ordinance.

“3(9) Awards” means grants of Awards to Israeli consultants, contractors or Controlling
Shareholders of the Company pursuant to the provisions of Section 3(9) of the Ordinance and

 

4

the rules and regulations promulgated thereunder, or any other section of the Ordinance that will
be relevant for such issuance in the future.

“Trust” means the holding of each Award and Exercised Shares by the Trustee in Trust for the
benefit of the Beneficial Grantee.

“Trustee” means a trustee designated by the Committee in accordance with the provisions of Section
3.4 hereof and, with respect to 102 Awards, approved by the Israeli Tax Authority.

“Trust Expiration Date” means 1.1.2015, or any other date determined by the Board.

“Trust Period” means the period of time required under a Taxation Route for Awards and/or Exercised
Shares to be held in Trust in order for the Beneficial Grantee to enjoy the tax benefits afforded
under such Taxation Route, as will be applicable for such Taxation Route from time to time.

“Vesting Period” of an Award means, for the purpose of the Plan and its related instruments, the
period between the Adoption Date and the date on which (i) an Option becomes exercisable into a
Share; or (ii) an RSU is automatically vested into a Share, as applicable.

C. GENERAL TERMS AND CONDITIONS OF THE PLAN

3. Administration:

          3.1 The Plan will be administered by the Board or, subject to applicable law, including but
not limited to the instructions of the Companies Law, by a Committee, which will consist of such
number of directors of the Company as may be fixed, from time to time, by the Board. If a Committee
is not appointed, the term Committee, whenever used herein, shall mean the Board. The Board shall
appoint the members of the Committee, may from time to time remove members from, or add members to,
the Committee and shall fill vacancies in the Committee however caused.

          3.2 The Committee shall select one of its members as its Chairman and shall hold its meetings
at such times and places, as it shall determine. Actions taken by a majority of the members of the
Committee, at a meeting at which a majority of its members is present, or acts reduced to, or
approved in, writing by all members of the Committee, shall be the valid acts of the Committee. The
Committee may appoint a secretary, who shall keep records of its meetings and shall make such rules
and regulations for the conduct of its business, as it shall deem advisable.

          3.3 Subject to the general terms and conditions of this Plan and applicable law, the Committee
shall have the full authority in its discretion, from time to time and at any time to determine (i)
the Grantees under the Plan, (ii) the number of Shares subject to each Award, (iii) the time or
times at which the same shall be granted, (iv) the schedule and conditions, including performance
conditions, if applicable, on which such Awards may be exercised and/or

 

5

on which such Shares shall be paid for and/or on which such RSUs may vest, and/or (v) rules and
provisions, as may be necessary or appropriate to permit eligible Grantees who are not Israeli
residents to participate in the Plan and/or to receive preferential tax treatment in their country
of residence, with respect to the Awards granted hereunder, and/or (vi) any other matter which is
necessary or desirable for, or incidental to, the administration of the Plan.

          3.4 Furthermore, subject to the general terms and conditions of the Plan, the Ordinance, and
any other applicable laws and regulations, the Committee shall have the full authority in its
discretion, from time to time and at any time, to determine:

               (a) With respect to grants of 102 Awards pursuant to the Taxation Route the identity of the
trustee who shall be granted such 102 Awards in accordance with the provisions of this Plan and the
Taxation Route; and

               (b) With respect to the grant of 3(9) Awards — whether or not 3(9) Awards shall be granted to
a trustee in accordance with the terms and conditions of this Plan, and the identity of the trustee
who shall be granted such 3(9) Awards in accordance with the provisions of this Plan.

          3.5 Notwithstanding the aforesaid, the Committee may, from time to time and at any time, grant
102(c) Awards.

          3.6 The Committee may, from time to time, adopt such rules and regulations for carrying out
the Plan, as it may deem necessary. No member of the Board or of the Committee shall be liable for
any act or determination made in good faith with respect to the Plan or any Award granted
thereunder.

          3.7 The interpretation and construction by the Committee of any provision of the Plan or of
any Award thereunder shall be final and conclusive and binding on all parties who have an interest
in the Plan or any Award or Share issuance thereunder, unless otherwise determined by the Board.

4. Eligible Grantees:

          4.1 The Committee, at its discretion, may grant Awards to any employee, director, consultant
and/or contractor of the Company. Anything in this Plan to the contrary notwithstanding, all grants
of Awards shall be authorized and implemented only in accordance with the provisions of applicable
law.

          4.2 The grant of an Award to a Grantee hereunder, shall neither entitle such Grantee to
participate, nor disqualify him from participating, in any other grant of Awards pursuant to this
Plan or any other incentive plan of the Company.

5. Grant of Awards, Issuance of Shares, Dividends and Shareholder Rights:

 

6

          5.1 Grant of Awards and Issuance of Shares.

               (a) Subject to the provisions of the Ordinance and applicable law (it being understood that,
unless otherwise determined by the Committee, the following shall not apply to Awards granted to
non Israeli Grantees),

                    (i) All grants of Awards to Israeli employees, directors and office holders of the Company,
other than to Controlling Shareholders, shall be as 102 Awards and shall be subject either to the
Taxation Route or to Section 102(c) of the Ordinance; and

                    (ii) All grants of Awards to Israeli consultants, contractors or Controlling Shareholders of
the Company shall be as 3(9) Awards.

               (b) Subject to Sections 7.1 and 7.2 hereof, the Date of Grant shall be the date the Committee
resolves to grant such Award, unless specified otherwise by the Committee in its determination
relating to the grant of such Award. The Committee shall promptly give the Grantee a Notice of
Grant.

               (c) Trust. In the event Awards are deposited with a Trustee, the Trustee shall hold
each such Award and Exercised Shares in Trust for the benefit of the Beneficial Grantee; provided,
however, that unless the Committee determines otherwise, in its sole and absolute discretion, the
Trustee shall not hold any Awards in Trust following the Trust Expiration Date, all Awards held in
Trust on such date shall be transferred automatically to the Grantee, and all implications,
including tax implications, resulting from such transfer of Awards shall be borne solely by the
Grantee.

                    In accordance with Section 102, the tax benefits afforded to 102 Awards and any Exercised
Shares, in accordance with the Taxation Route, shall be contingent upon the Trustee holding such
102 Awards for the applicable Trust Period.

                    With respect to 102 Awards granted to the Trustee, the following shall apply:

                    (i) A Grantee granted 102 Awards shall not be entitled to sell the Exercised Shares or to
transfer such Exercised Shares (or such 102 Awards) from the Trust prior to the lapse of the Trust
Period; and

                    (ii) Any and all Rights shall be issued to the Trustee and held thereby until the lapse of the
Trust Period, and such Rights shall be subject to the Taxation Route.

                    Notwithstanding the aforesaid, Exercised Shares or Rights may be sold or transferred, and the
Trustee may release such Exercised Shares (or 102 Awards) or Rights from Trust, prior to the lapse
of the Trust Period, provided however, that tax is paid or withheld in accordance with Section 102
of the Ordinance and/or the 102 Rules, and/or any

 

7

other provision of the Ordinance and any regulation, ruling, procedure and clarification
promulgated thereunder, that will be relevant from time to time.

                    All certificates representing Exercised Shares issued to the Trustee under the Plan shall be
deposited with the Trustee, and shall be held by the Trustee until such time that such Shares are
released from the Trust as herein provided.

                    Alternatively, in the event the Company’s Shares are listed on any stock exchange or admitted
to trading on an electronic securities trading system, whether in Israel or outside of Israel, the
Company shall register the Exercised Shares issued to the Trustee pursuant to the Plan, in the name
of the Trustee, in accordance with any applicable laws, rules and regulations, until such time that
such Shares are released from the Trust as herein provided.

          (d) Subject to the terms hereof, at any time after the Awards are vested, with respect to any
102 Awards or Exercised Shares held by the Trustee the following shall apply:

                    (i) Upon the written request of any Beneficial Grantee, the Trustee shall release from the
Trust, within a reasonable period of time, the Awards granted, and/or the Exercised Shares issued,
on behalf of such Beneficial Grantee, by executing and delivering to the Company such instrument(s)
as the Company may require, giving due notice of such release to such Beneficial Grantee,
provided, however, that the Trustee shall not so release any such Awards and/or
Exercised Shares to such Beneficial Grantee unless the latter, prior to, or concurrently with, such
release, provides the Trustee with evidence, satisfactory in form and substance to the Trustee,
that all taxes, if any, required to be paid upon such release have, in fact, been paid.

                    (ii) Alternatively, subject to the terms hereof, with respect to any Exercised Shares held by
the Trustee, provided the Exercised Shares are listed on a stock exchange or admitted to trading on
an electronic securities trading system (such as the Nasdaq), upon the written instructions of the
Beneficial Grantee to sell any Exercised Shares, the Company and/or the Trustee shall use their
reasonable efforts to effect such sale within a reasonable period of time, and shall transfer such
Exercised Shares to the purchaser thereof concurrently with the receipt of, or after having made
suitable arrangements to secure, the payment of the proceeds of the purchase price in such
transaction. The Company and/or the Trustee, as applicable, shall withhold from such proceeds any
and all taxes required to be paid in respect of such sale, shall remit the amount so withheld to
the appropriate tax authorities and shall pay the balance thereof directly to the Beneficial
Grantee, reporting to such Beneficial Grantee and to the Company the amount so withheld and paid to
said tax authorities. In case an appropriate tax exemption or partial tax exemption certificate was
provided to the Company and/or Trustee, an adequate time prior to the date in which the proceeds
are to be paid, the Company and/or Trustee shall not withhold or partially withhold the taxes
required, in accordance with the tax exemption certificate, as the case may be).

 

8

          5.2 Guarantee. In the event a 102(c) Award is granted to a Grantee who is an employee
at the time of such grant, upon the Grantee’s Cessation of Employment, such Grantee shall provide
the Company, to its full satisfaction, with a guarantee or collateral securing the future payment
of all taxes required to be paid upon the sale of the Exercised Shares received upon exercise of
such 102(c) Award or its vesting (if an RSU), all in accordance with the provisions of Section 102
of the Ordinance, the 102 Rules and the regulation or orders promulgated thereunder.

          5.3 Dividend. All Exercised Shares shall entitle the Grantee thereof to receive
dividends with respect thereto. For so long as Exercised Shares deposited with the Trustee on
behalf of a Beneficial Grantee are held in the Trust, the cash dividends paid or distributed with
respect thereto shall be distributed directly to such Beneficial Grantee, subject to any applicable
taxation on distribution of dividends, and when applicable subject to the provisions of Section 102
of the Ordinance, the 102 Rules and the regulations or orders promulgated thereunder.

          5.4 Voting Rights; Shareholder Rights. The holder of an Award shall have no
shareholder rights with respect to the Shares subject to such Award until such person shall have
exercised the Award, or the Award has vested (if an RSU), as the case may be, has paid the Exercise
Price, if applicable, and has become the record holder of the applicable Exercised Shares.

               As long as the Exercised Shares are held by the Trustee, the voting rights at the Company’s
general meeting attached to such Exercised Shares will remain with the Trustee. The Trustee shall
not be obligated to exercise such voting rights at general meetings, nor to notify the Grantee of
any Exercised Shares held in the Trust, of any meeting of the Company’s shareholders. However, the
Trustee may, at his sole discretion, empower the respective Beneficial Grantee, to vote in name and
in place of the Trustee according to such Beneficial Grantee’s instructions, if provided.

6. Reserved Shares: The total number of Shares that may be subject to Awards granted under this
Plan shall not exceed 2,500,000 in the aggregate, subject to adjustments as provided in Section 11
hereof. All Shares under the Plan, in respect of which the right of a Grantee to purchase the same
shall, for any reason, terminate, expire or otherwise cease to exist, shall again be available for
grant through Awards under the Plan, and under any other plans or sub-plans, as the Committee may
determine at its own discretion, from time to time, provided, however, that until termination of
the Plan the Company shall at all times reserve sufficient number of unissued Shares to meet the
requirements of the Plan.

          Without derogating from the foregoing, the Committee shall have full authority in its
discretion to determine that the Company may issue, for the purposes of this Plan and/or any other
plans, previously issued Shares that are held by the Company, from time to time, as Dormant Shares
(as such term is defined in the Companies Law).

 

9

          7. Required Approvals; Notice of Grant; Vesting and Re-pricing:

          7.1 The implementation of the Plan and the grant of any Award under the Plan shall be subject
to the Company’s procurement of all approvals and permits required by applicable law or regulatory
authorities having jurisdiction over the Plan, the Awards granted under it, and the Exercised
Shares issued pursuant to it.

               The Company shall obtain the approval of the Company’s shareholders for the adoption of this
Plan or for any amendment or sub-plan adopted in the future to this Plan, if shareholders’ approval
is necessary to comply with the Company’s bylaws, any applicable law, rule or regulation, including
without limitation the US securities laws, or the securities laws of other jurisdictions applicable
to Awards granted to Grantees under this Plan, or if shareholders’ approval is required by any
authority or by any governmental agencies or national securities exchanges, including without
limitation the US Securities and Exchange Commission.

          7.2 The Notice of Grant shall state, inter alia, the number of Shares subject to each Award,
the vesting schedule, the dates when the Awards may be exercised or shall automatically vest into
Exercised Shares (for RSUs), as applicable, their Exercise Price, if applicable, whether the Awards
granted to Israeli Grantees are 102 Awards (and in particular whether the 102 Awards are granted
under the Taxation Route, or as 102(c) Awards) or 3(9) Awards, and such other terms and conditions
as the Committee at its discretion may prescribe, provided that they are consistent with this Plan.
Each Notice of Grant evidencing a 102 Award shall, in addition, be subject to the provisions of the
Ordinance applicable to such awards.

               Furthermore, each Grantee of a 102 Award under the Taxation Route shall be required to execute
a declaration stating that he or she is familiar with the provisions of Section 102 of the
Ordinance and the Taxation Route, and to undertake not to sell or transfer the Awards and/or the
Exercised Shares prior to the lapse of the applicable Trust Period, unless he or she pays all taxes
that may arise in connection with such sale and/or transfer.

          7.3 Term of Awards; Vesting. Without derogating from the rights and powers of the
Committee under Section 7.2 hereof and subject to Section 10 hereinafter, unless otherwise
specified by the Committee, the Awards shall be for a term of six (6) years, and, unless determined
otherwise by the Committee, the Vesting Period pursuant to which such Awards shall vest, shall be
such that 25% of the Awards granted to a Grantee in a specific grant shall vest on each of the
first, second, third and fourth anniversaries of the Adoption Date; provided, however, that
no Award granted under this Plan shall vest prior to the consummation of an IPO.

               Unless determined otherwise by the Committee, any period in which the Grantee shall not be
employed by the Company, or in which the Grantee shall have taken an unpaid leave of absence, or in
which the Grantee shall cease to serve as a director, consultant or contractor of the Company,
shall not be included in the Vesting Period.

 

10

          7.4 Acceleration of Vesting. Anything herein to the contrary in this Plan
notwithstanding, the Committee shall have full authority, whether
before or after the grant of an
Award, to determine any provisions regarding the acceleration of the Vesting Period of any Award,
or the cancellation of all or any portion of any outstanding restrictions with respect to any Award
upon certain events or occurrences, on such terms and conditions as the Committee shall deem
appropriate.

          7.5 Repricing. Subject to applicable law, the Committee shall have full authority to,
at any time and from time to time, (i) grant in its discretion to the holder of an outstanding
Award, in exchange for the surrender and cancellation of such Award, a new Award having
an Exercise Price lower than provided in the Award so surrendered and
canceled and containing such other terms and conditions as the Committee may prescribe in
accordance with the provisions of the Plan, or (ii) effectuate a decrease in the Exercise
Price (see Section 8 below) of outstanding Awards.

          8. Exercise Price: The Exercise Price shall be determined by the Committee in its sole and
absolute discretion, subject to applicable law and to guidelines adopted by the Board from time to
time.

          9. Exercise of Options:

          9.1 Options shall be exercisable pursuant to the terms under which they were awarded and
subject to the terms and conditions of the Plan.

          9.2 The exercise of an Option shall be made by a written Notice of Exercise delivered by the
Grantee to the Company at its principal executive office, and/or to a Representative and, with
respect to Options held in the Trust, to the Trustee, in such form and method as may be determined
by the Company and when applicable, by the Trustee in accordance with the requirements of Section
102 of the Ordinance, specifying the number of Shares to be purchased and accompanied by the
payment of the Exercise Price, at the Company’s or the Representative’s principal office, and
containing such other terms and conditions as the Committee shall prescribe from time to time.

          9.3 Notwithstanding the provisions of Section 9.2 above, and unless otherwise provided by the
Board, all Options shall be exercised using the following method (the “Net Exercise”):

                         (a) The Company shall issue to the Grantee (or to the Trustee, as applicable) a number of
Shares having an aggregate Market Value (as defined below) equal to the Benefit Amount (as defined
below) (the “Net Exercise Shares”);

                         For the purposes of this Section:

                         (i) The “Benefit Amount” shall mean the difference between:

 

11

                         (A) (i) the Market Value times (ii) the number of Shares subject to the Options for which a
Notice of Exercise has been delivered to the Company; and

                         (B) (i) the Exercise Price times (ii) the number of Shares subject to the Options for which a
Notice of Exercise has been delivered to the Company.

                    (ii) “Market Value” shall mean the closing price for a Share on the last trading day prior to
the date of exercise, as reported or quoted on the Nasdaq or on any other stock market on which
Shares are traded, as shall be determined by the Committee.

               (b) The Grantee shall not be required to pay to the Company any sum with respect to the
exercise of such Options, other than a sum equal to [the aggregate nominal value of the Net
Exercise Shares (which shall be paid in a manner provided in Section 9.5 below) (the “Nominal Value
Sum”). However, the Company shall have the full authority in its discretion to determine at any
time that the Nominal Value Sum shall not be paid and that the Company shall capitalize applicable
profits or take any other action to ensure that it meets any requirement of applicable law
regarding issuance of Shares for consideration that is lower than the nominal value of such Shares;

               (c) No fractional Shares will be issued to the Grantee and the number of Shares granted to the
Grantee under the Plan shall be rounded off (upward or downward) to the nearest whole number.

          9.4 Anything herein to the contrary notwithstanding, but without derogating from the
provisions of Section 10 hereof, unless otherwise determined by the Committee, if any Option has
not been exercised and the Shares subject thereto not paid for within six (6) years after the Date
of Grant (or any shorter period set forth in the Notice of Grant), such Option and the right to
acquire such Shares shall terminate, all interests and rights of the Grantee in and to the same
shall ipso facto expire, and, in the event that in connection therewith any Options are still held
in the Trust as aforesaid, the Trust with respect thereto shall ipso facto expire, and the Shares
subject to such Options shall again be available for grant through Awards under the Plan (provided
its term is extended, if needed), any other plans or sub-plans, as provided for in Section 6
herein, or any other incentive arrangement of the Company.

          9.5 Each payment for Exercised Shares shall be in respect of a whole number of Shares, and
shall be effected in cash or by a bank’s check payable to the order of the Company, or such other
method of payment acceptable to the Company.

10. Termination of Employment:

          10.1 Employees. In the event of a Cessation of Employment of a Grantee who was an
employee at the Date of Grant, all Awards theretofore granted to such Grantee when such Grantee was
an employee of the Company, unless determined otherwise by the Committee, shall terminate as
follows:

 

12

                         (a) All such Awards that are not vested on the Date of Cessation shall terminate immediately.

               (b) If the Grantee’s cessation of employment is by reason of such Grantee’s death or
Disability, any Options previously granted to the Grantee (to the extent vested on the Date of
Cessation) shall be exercisable by the Grantee (if applicable) or the Grantee’s guardian, legal
representative, estate or other person to whom the Grantee’s rights are transferred by will or by
laws of descent or distribution, at any time until the lapse of twelve (12) months from the Date of
Cessation (but in no event after the expiration date of such Options), and shall thereafter
terminate.

               (c) If the Grantee’s Cessation of Employment is due to any reason other than those stated in
Sections 11.1(b), 11.1(d) or 11.1(e) herein, any Options previously granted to the Grantee (to the
extent vested on the Date of Cessation) shall be exercisable at any time until the lapse of three
(3) months from the Date of Cessation (but in no event after the expiration date of such Options),
and shall thereafter terminate;

               (d) Notwithstanding the aforesaid, if the Grantee’s Cessation of Employment is due to (i)
breach of the Grantee’s duty of loyalty towards the Company, or (ii) breach of the Grantee’s duty
of care towards the Company, or (iii) the commission of any flagrant criminal offense by the
Grantee, or (iv) the commission of any act of fraud, embezzlement or dishonesty towards the Company
by the Grantee, or (v) any unauthorized use or disclosure by the Grantee of confidential
information or trade secrets of the Company, or any substantial breach of the Grantee’s employment
agreement with the Company, or (vi) any other intentional misconduct by the Grantee (by act or
omission) adversely affecting the business or affairs of the Company in a material manner, or (vii)
any act or omission by the Grantee which would allow for the termination of the Grantee’s
employment without severance pay, according to the Severance Pay Law, 1963, any and all Options
previously granted to the Grantee whether vested or not shall ipso facto expire immediately and be
of no legal effect.

               (e) If a Grantee retires, he may, subject to the approval of the Committee, continue to enjoy
such rights, if any, under the Plan and on such terms and conditions, with such limitations and
subject to such requirements as the Committee in its discretion may determine.

               (f) Whether the Cessation of Employment of a particular Grantee is by reason of “Disability”
for the purposes of paragraph 10.1(b) hereof or by virtue of “retirement” for purposes of paragraph
10.1(e) hereof, or is a termination of employment other than by reason of such Disability or
retirement, or is for reasons as set forth in paragraph 10.1(d) hereof, shall be finally and
conclusively determined by the Committee in its absolute discretion.

 

13

               (g) Notwithstanding the aforesaid, under no circumstances shall any Option be exercisable
after the specified expiration of the term of such Option.

          10.2 Directors, Consultants and Contractors. In the event that a Grantee, who is a
director, consultant or contractor of the Company, ceases, for any reason, to serve as such, the
provisions of Sections 10.1(a), 10.1(b), 10.1(c), 10.1(d), 10.1(f) and 10.1(g) above shall apply,
mutatis mutandis.

          10.3 Notwithstanding the foregoing provisions of this Section 10, the Committee shall have the
discretion, exercisable either at the time an Option is granted or thereafter, to:

               (a) Extend the period of time for which the Option is to remain exercisable following the Date
of Cessation to such greater period of time, as the Committee shall deem appropriate, but in no
event beyond the specified expiration of the term of the Option; or

               (b) Permit the Option to be exercised, during the applicable exercise period following the
Date of Cessation, not only with respect to the number of Shares for which such Option is
exercisable on the Date of Cessation but also with respect to one or more additional installments
in which the Grantee would have vested under the Option had the Grantee continued in the employ or
service of the Company.

          10.4 Notwithstanding the foregoing provisions of this Section 10, and for the avoidance of
doubt, unless the Board determines otherwise, the transfer of a Grantee from the employ or service
of the Company to the employ or service of an Affiliate, or from the employ or service of an
Affiliate to the employ or service of the Company or another Affiliate, shall not be deemed a
Cessation of Employment or termination of service for purposes hereof.

11. Adjustments, Liquidation and Corporate Transaction:

          11.1 Bonus Shares.

               (a) If the Company distributes bonus shares to all of its shareholders, including all holders
of Shares, whose date of distribution is earlier than the Exercise Date or vesting date (for RSUs),
as applicable, Shares in the number and kind that the Award holder would have been entitled to as
bonus shares had he/she exercised the Options or had his/her RSUs vested, as the case may be,
before the record date determining the right to receive bonus shares, will be added to the
Exercised Shares to which the holder of the Awards is entitled upon exercising the Options or
vesting of the RSUs, as applicable.

                    (b) The Exercise Price of each Award will not change as a result of the addition of such bonus
shares, while other terms referring to the Exercised Shares will also apply to the bonus shares
added to the Exercised Shares, mutatis mutandis.

 

14

                    (c) If the Company distributes bonus shares, as described in Section (a) above, for which the
record date for distribution and/or the date of distribution fall during the period in which
Exercised Shares are registered in the name of the Trustee for the Beneficial Grantee, the Company
will transfer to the Trustee an amount of bonus shares according to the number of Exercised Shares
registered in its name at the time of distribution, and the Trustee will hold them in Trust for the
Beneficial Grantees. In the event Exercised Shares have been transferred from the Trustee to a
Beneficial Grantee and/or sold by the Company or the Trustee at the Beneficial Grantee’s request
between the record date for distribution and the date of distribution, the Company will transfer
bonus shares in respect of these Shares directly to such Beneficial Grantee. Each such Grantee will
be entitled to Shares in the same number and class to which he would have been entitled, had the
Shares been held by him prior to the record date for the right to receive the bonus shares.

          11.2 Cash Dividends. If the Company distributes cash dividends with respect to all
Company’s Shares issued to its shareholders, and the record date for determining the right to
receive such dividends (the “Determining Date”) is earlier than the Exercise Date of the Options
granted hereunder, then the Exercise Price for each Share subject to an Option not exercised prior
to the Determining Date, shall be reduced by an amount equal to the gross amount of the dividend
per Share distributed, calculated in the same currency as the Exercise Price according to the
representative rate of exchange as of the Determining Date, if applicable. Notwithstanding the
aforesaid, in the event the Company’s Shares are listed on any stock exchange or admitted to
trading on an electronic securities trading system as of the Determining Date, the aforesaid
reduction of the Exercise Price for each Share subject to an Option not exercised shall correspond
to the reduction in the price of a Company Share as a result of such distribution as recorded by
such stock exchange or electronic securities trading system. Unless determined otherwise by the
Board, the Exercise Price shall not be reduced to less than the nominal value of a Share.

          11.3 Adjustments. Unless determined otherwise by the Committee, subject to any
required action by the shareholders of the Company and/or any other required action under any
applicable law, the number of Shares subject to each outstanding Award, and the number of Shares
which have been authorized for issuance under the Plan but as to which no Awards have yet been
granted or which have been returned to the Plan upon cancellation or expiration of an Award, as
well as the price per share of Shares subject to each such outstanding Award, shall be
proportionately adjusted for any increase or decrease in the number of issued Shares resulting from
a share split, reverse share split, combination or reclassification of the Shares or any other
increase or decrease in the number of issued Shares effected without receipt of consideration by
the Company; provided, however, that conversion of any convertible securities of
the Company shall not be deemed to have been “effected without receipt of consideration.” Such
adjustment shall be made by the Committee, whose determination in that respect shall be final,
binding and conclusive.

 

15

               Except as expressly provided in this Section 12, no issuance by the Company of shares of any
class, or securities convertible into shares of any class, shall affect, and no adjustment by
reason thereof shall be made with respect to, the number or price of Shares subject to an Award.

               Except as expressly provided in this Section 11, the grant of Awards under the Plan shall in
no way affect the right of the Company to distribute bonus shares, to offer rights to purchase its
securities, or to distribute cash dividends.

          11.4 Liquidation. Unless otherwise provided by the Board, in the event of the
proposed dissolution or liquidation of the Company, all outstanding Awards will terminate
immediately prior to the consummation of such proposed action. In such case, the Committee may
declare that any Award shall terminate as of a date fixed by the Committee and give each Grantee
the right to exercise his/her Award or to allow his/her Awards to vest (for RSUs), including any
Award that would not otherwise be vested (in respect of RSUs) and/or exercisable (in respect of
Options).

          11.5 Corporate Transaction.

               (a) In the event of a Corporate Transaction, the Vesting Period of the Awards shall be
automatically and immediately accelerated so that all Awards whether vested or not shall become
vested and, in respect of Options, exercisable, as of ten (10) days prior to the effective date of
such Corporate Transaction and until the effective date of such Corporate Transaction.

               (b) Immediately prior the consummation of the Corporate Transaction, all outstanding Awards
which are not exercised until the effective date of the Corporate Transaction, shall terminate and
cease to be outstanding.

          11.6 Sale. Subject to any provision in the Articles of Association of the Company and
to the Committee’s sole and absolute discretion, in the event of sale or other disposition of all
or substantially all of the outstanding share capital of the Company, each Grantee shall be
obligated to participate in such sale and sell his or her Exercised Shares, provided,
however, that each such Exercised Share shall be sold at a price equal to that of any other
Share sold under the sale, subject to the absolute discretion of the Board.

               With respect to Exercised Shares held in Trust the following procedure will be applied: the
Trustee will transfer the Exercised Shares held in Trust and sign any document in order to
effectuate the transfer of such Shares, including share transfer deeds, provided,
however, that the Trustee receives a notice from the Board, specifying that: (i) all or
substantially all of the issued outstanding share capital of the Company is to be sold, and
therefore the Trustee is obligated to transfer the Exercised Shares held in Trust under the
provisions of this Section 11.5; and (ii) the Company is obligated to withhold at source all taxes
required to be paid upon release of the Exercised Shares from the Trust and to provide the Trustee
with evidence, satisfactory to the Trustee, that such taxes indeed have been paid;

 

16

and (iii) the Company is obligated to transfer the consideration for the Exercised Shares directly
to the Grantees.

          11.7 The grant of Awards under the Plan shall in no way affect the right of the Company to
adjust, reclassify, reorganize or otherwise change its capital or business structure or to merge,
consolidate, dissolve, liquidate or sell or transfer all or any part of its business or assets.

12. Limitations on Transfer:

          12.1 Unless determined otherwise by the Committee, no Award shall be assignable or
transferable by the Grantee to whom granted otherwise than by will or the laws of descent and
distribution, and an Award may be exercised, where applicable, during the lifetime of the Grantee
only by such Grantee or by such Grantee’s guardian or legal representative. Any assignment or
transfer other than as aforesaid, shall be null and void. The terms of such Award shall be binding
upon the beneficiaries, executors, administrators, heirs and successors of such Grantee. In
addition, as long as Awards and/or Exercised Shares are held by the Trustee on behalf of the
Grantee, all rights of the Grantee over the Exercised Shares are personal, cannot be transferred,
assigned, pledged or mortgaged, other than by will or pursuant to the laws of descent and
distribution.

          12.2 Underwriter’s Lock-up. The Grantee’s rights to sell Exercised Shares may be
subject to certain limitations (including a lock-up period), as will be requested by the Company or
its underwriters, from time to time, or upon a specific occurrence, and the Grantee unconditionally
agrees and accepts any such limitations.

          12.3 Restrictions on Shares. The Committee may impose such restrictions on any
Exercised Shares, as it may deem advisable, including, but not limited to, restrictions related to
applicable U.S. federal securities laws, the requirements of any national securities exchange or
system upon which Shares are then listed or traded, or any U.S. blue sky or state securities laws.

13. Restricted Stock Units

          13.1 Subject to the sole and absolute discretion and determination of the Committee, the
Committee may decide to grant under this Plan, in addition to, or instead of, any grant of Options,
Restricted Stock Unit(s) (“RSU(s)”). RSUs are Options, bearing an Exercise Price of no more than
the underlying Share’s nominal value. In addition, notwithstanding anything to the contrary in
Section 9.2 above, upon the lapse of the Vesting Period of an RSU, such RSU shall automatically
vest into an Exercised Share of the Company and, unless otherwise determined by the Board, the
Grantee shall pay to the Company its nominal value as a precondition to any issuance of such
Exercised Share. However, the Company shall have the full authority in its discretion to determine
at any time that the nominal value shall not be paid and that the Company shall capitalize
applicable profits or take any other action to
ensure that it meets any requirement of applicable law regarding issuance of shares for
consideration that is lower

 

17

than the nominal value of such Shares.

          13.2 All other terms and conditions of this Plan applicable to Options, shall apply to RSUs
mutatis mutandis.

14. Term and Amendment of the Plan:

          14.1 The Plan shall terminate, and no additional Awards may be granted pursuant to it, upon
the earliest of (i) the expiration of ten (10) years from the date the Plan was adopted by the
Board, or (ii) the termination of all outstanding Awards in connection with a Corporate
Transaction. All Awards outstanding at the time of a clause (i) termination event shall continue to
have full force and effect in accordance with the provisions of the Plan and the documents
evidencing such Awards.

          14.2 Subject to applicable laws and regulations, the Board in its discretion may, at any time
and from time to time, amend, alter, extend or terminate the Plan, as it deems advisable. However,
no amendment or modification shall adversely affect any rights and obligations with respect to
Options at the time outstanding under the Plan, unless the applicable Grantee consents to such
amendment or modification. In the event the Committee wishes to grant Awards to non-Israeli
Grantees, the Committee may adopt, as part of this Plan and based on it, sub-plans, in order to
comply with all relevant and applicable laws and regulations of the country of residence of such
Grantees.

15. Withholding and Tax Consequences: The Company’s obligation to deliver Exercised Shares upon the
exercise or vesting of any Awards granted under the Plan shall be subject to the satisfaction of
all applicable income tax and other compulsory payments withholding requirements. All tax
consequences and obligations regarding any other compulsory payments arising from the grant,
exercise, or vesting of any Award, from the payment for, or the subsequent disposition of,
Exercised Shares subject thereto or from any other event or act (of the Company, of the Trustee or
of the Grantee) hereunder, shall be borne solely by the Grantee, and the Grantee shall indemnify
the Company and/or the Trustee, as applicable, and hold them harmless against and from any and all
liability for any such tax or other compulsory payment, or interest or penalty thereon, including
without limitation, liabilities relating to the necessity to withhold, or to have withheld, any
such tax or other compulsory payment from any payment made to the Grantee.

          The Company and/or the Trustee, when applicable, shall not be required to release any Share
certificate to a Grantee until all required payments have been fully made.

 

18

16. Miscellaneous:

          16.1 Continuance of Employment. Neither the Plan nor the grant of an Award thereunder
shall impose any obligation on the Company to continue the employment or service of any Grantee.
Nothing in the Plan or in any Award granted thereunder shall confer upon any Grantee any right to
continue in the employment or service of the Company for any period of specific duration, or
interfere with or otherwise restrict in any way the right of the Company to terminate such
employment or service at any time, for any reason, with or without cause.

          16.2 Notwithstanding anything to the contrary in this Plan, it is hereby clarified, that any
income attributed (or deemed to be attributed) to the Grantee as a result of this Plan, the grant
or exercise of Awards thereunder, or the sale of Exercised Shares, shall not be taken into account
for the purpose of calculating the Grantee’s eligibility for any rights deriving from the
employee-employer or service provider-client relationship between the Grantee and the Company.

          16.3 Governing Law. The Plan and all instruments issued thereunder or in connection
therewith, shall be governed by, and interpreted in accordance with, the laws of the State of
Israel, excluding the choice of law rules thereof.

          16.4 Application of Funds. Any proceeds received by the Company from the sale of
Exercised Shares pursuant to the Awards granted under the Plan shall be used for general corporate
purposes of the Company.

          16.5 Multiple Agreements. The terms of each Award may differ from other Awards
granted under the Plan at the same time, or at any other time. The Committee may also grant more
than one Award to a given Grantee during the term of the Plan, either in addition to, or in
substitution for, one or more Awards previously granted to that Grantee. The grant of multiple
Awards may be evidenced by a single Notice of Grant or multiple Notices of Grant, as determined by
the Committee.

          16.6 Non-Exclusivity of the Plan. The adoption of the Plan by the Board shall not be
construed as amending, modifying or rescinding any previously approved incentive arrangement or as
creating any limitations on the power of the Board to adopt such other incentive arrangements as it
may deem desirable, including, without limitation, the granting of awards otherwise than under the
Plan, and such arrangements may be either applicable generally or only in specific cases.

          16.7 The provisions of this Plan shall not be construed as deviating from any applicable laws,
rules and regulations.

*****

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]